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ABSTRACT 
 
The Molecular Mechanisms Involved in the Genetic Instability of the CCTG•CAGG 
Repeats Associated with Myotonic Dystrophy Type 2.  (May 2006) 
Ruhee J. Dere, B.S., University of Mumbai; 
M.S., University of Mumbai 
Chair of Advisory Committee:  Dr. Robert D. Wells 
 
 
 
Myotonic dystrophy type 2 (DM2) is caused by the extreme expansion (from < 
30 repeats in normal individuals to ~ 11,000 for the full mutation in certain patients) of 
the repeating tetranucleotide CCTG•CAGG sequence in the intron of the zinc finger 
protein 9 (ZNF9) gene.  The genetic instabilities of the CCTG•CAGG repeats were 
investigated to evaluate the molecular mechanisms responsible for these massive 
expansions.  The effects of replication, recombination, repair and transcription on the 
genetic instabilities have been investigated in COS-7 cells and E. coli model systems.  A 
replication assay was established in COS-7 cells wherein the CCTG•CAGG repeats 
cloned proximal to the SV40 origin of replication resulted in expansions and deletions in 
a length and orientation-specific manner, whereas the repeats cloned distal to the same 
origin were comparatively stable.  These results fit with our data obtained from 
biochemical studies on synthetic oligonucleotides since these biochemical studies 
revealed that the d(CAGG)26 oligomer had a marked propensity to adopt a hairpin 
structure as opposed to its complementary d(CCTG)26 that lacked this capacity.  
 iv
Furthermore, a genetic assay in E. coli was used to monitor the intramolecular frequency 
of recombination.  This assay revealed that the tetranucleotide repeats were indeed hot 
spots for recombination.  Moreover, studies conducted in SOS-repair mutants showed 
that recombination frequencies were much lower in a SOS¯ strain as compared to a SOS+ 
strain.  However, experiments conducted to ascertain the level of induction of the SOS 
response revealed that the SOS pathway was not stimulated in our studies.  These results 
revealed that although breaks may occur within the repeats, the damage is most likely 
repaired without induction of the SOS response contrary to previous beliefs.   
 Thus, a complex interplay of replication, recombination, and repair is likely 
responsible for the expansions observed in DM2. 
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CHAPTER I 
INTRODUCTION 
 
A.  Overview 
 The genetic instabilities associated with hereditary neurological diseases have 
been studied extensively, since the discovery, in 1991, of the CGG•CCG expansion 
causative of the Fragile X syndrome (1-3).  Although, repetitive sequences are found 
dispersed all over the human genome only a handful of these repeat tracts at certain loci 
have been implicated in a disease phenotype.  Analyses of these repeats has lead to the 
identification of several cis-elements that contribute to the instability of the repeat tracts 
including, repeat sequence, the length and purity of the repeat tracts, sequences flanking 
the repeats, DNA methylation and chromatin structure (4).  Numerous groups have 
conducted experiments in several model systems to implicate cellular pathways 
including, DNA replication, repair, recombination, and transcription in generating the 
dynamic mutations observed with these microsatellite disorders (5-8).  The ability of the 
repetitive DNA sequences, including CTG•CAG, CGG•CCG, GAC•GTC, GAA•TTC, 
CCTG•CAGG and ATTCT•AGAAT to adopt non-B DNA structures such as hairpins, 
triplexes and tetraplexes has been proposed to be a source for mutagenesis (5-8).  
Herein, the important aspects of hereditary neurological diseases have been reviewed. 
——————— 
This dissertation follows the style of the Journal of Biological Chemistry. 
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B.  Microsatellite instabilities 
 Microsatellite sequences usually have tandem arrays ranging between one to six 
base pairs and are a part of a larger family of tandem repetitive sequences (9-11).  These 
microsatellites are highly abundant, polymorphic and are widespread in all eukaryotic 
genomes from yeast to mammals (12).  In mycoplasma and bacteria the genetic 
polymorphisms of these sequences play a vital role in phase variation that controls gene 
expression (13).  In the past decade a new pathway for the development of cancers in 
humans has emerged, that is characterized by the inactivation of the DNA mismatch 
repair system leading to a hypermutable state in which microsatellites become unstable 
during DNA replication (14-17).  Although this instability was first discovered in 
hereditary nonpolyposis colorectal carcinoma (HNPCC) (16,18-22), the number of 
diseases characterized by these microsatellite instabilities has increased to include 
gastric adenocarcinomas, pancreatic carcinomas, prostatic adenocarcinomas, small-cell 
lung carcinomas, renal carcinomas as well as carcinomas of the endometrium (23-28).  
Additionally, microsatellites are used extensively in genetic mapping (29-33), paternity 
testing (34) and forensic medicine (35,36).  A growing number of neurological diseases 
result from the expansion of a particular class of microsatellites called trinucleotide 
repeats [reviewed in (4,6,37-39)].  More recently this class of neurological diseases has 
broadened to include a tetranucleotide, pentanucleotide and even a dodecamer repeating 
tract (4,40-42).   
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C.  Trinucleotide repeat diseases  
 The expansion of several trinucleotide repeat sequences (TRS) has been 
associated with almost 30 hereditary neurological diseases including the Fragile X 
syndrome (FRAXA), myotonic dystrophy type 1 (DM1), Friedreich’s ataxia (FRDA), 
Huntington’s disease (HD) as well as the spinocerebellar ataxia’s (SCAs) (4-6,38) (Fig. 
1).  Most of these diseases exhibit genetic anticipation, a term used to describe the 
increase in disease severity and an earlier age of onset from one generation to the next 
(5,38).  Furthermore, the term ‘dynamic mutation’ is also used to describe these 
repetitive sequences as there is a greater propensity for the expanded triplet repeats to 
undergo further expansions in subsequent generations (43).  Repeat instability can either 
occur throughout the genome or at a particular locus within the genome.  Genome-wide 
instability occurs in several cancers (4) however, the instability associated with the 
triplet repeat disorders is locus-specific (44-46).  Thus, the expansion of the repeats 
alters the expression levels or the biological activity of the gene at that particular locus.  
These expansions have been found in coding as well as non-coding regions and the 
threshold number of repeats beyond which the disease manifests itself is different for 
each disorder.  Based on the location of the repeat within the disease gene, the triplet 
repeat diseases have been classified into two distinct categories.   
 1.  Type I diseases.  The type I diseases are characterized by the presence of the 
repeats within the coding region of a gene (Fig. 1).  These repeats have been identified 
as CAG•CTG tracts encoding polyglutamine, and are associated with several 
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neurological diseases including HD, Haw River syndrome (DRPLA), Kennedy’s disease 
(SBMA) as well as a number of spinocerebellar ataxia’s (SCA1, 2, 3, 6, 7, and 17) (5,37-
39,47,48).  In addition to the polyglutamine diseases this category also consists of the 
GAC•GTC repeats found in the cartilage oligomeric matrix protein (COMP) gene 
associated with multiple skeletal dysplasia’s (49-51).  Recently, polyalanine tract 
expansions (encoded by the GCG•CGC repeats) have been shown to cause nine human 
conditions most of which occur in transcription factor genes (52-56).  The expansions of 
the repeats in type I diseases are small, between 40 to a 100 repeats and are characterized 
by a progressive neuronal loss (5,37).  Although the genetics of these polyglutamine 
diseases are well defined, the molecular mechanism itself is poorly understood and is 
currently being investigated.  The mutated protein has been found to form insoluble 
aggregates in the cytoplasm and nucleus of neurons (57-60).  These inclusions have been 
hypothesized to affect neurons through the alteration of gene transcription, steric 
interference with cellular activities and the activation of apoptotic or other signaling 
pathways (61,62).   
 2.  Type II diseases.  In these diseases, the repeat expansions occur in the non-
coding regions of genes (Fig. 1) and are characterized by large expansions (up to several 
thousand repeats) in affected individuals.  Most of these diseases show a premutation 
size before a full mutation occurs in subsequent generations (4,5,37).  A CGG•CCG 
expansion in the 5` untranslated region (UTR) of the FMR1 gene is associated with the 
Fragile X syndrome (2).  The mutational basis of this disorder involves the 
 5
 
 
 
FIG. 1.  Genomic location of the repeating sequences.  The repeating tracts are found either in the 
coding (exons) or non-coding (introns, 5` - UTR or the 3` - UTR) regions of the gene.  The repeating 
sequences causing each of the disorders are placed in parenthesis above all the disorders implicating that 
particular repeating tract.   
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hypermethylation of CpG islands in the promoter of the FMR1 gene leading to its 
transcriptional repression (63-65).  The DM1 and the SCA8 CTG•CAG sequences 
expand in the 3` UTR of the dystrophia myotonica protein kinase (DMPK) and SCA8 
gene, respectively (66-71).  Both of these disorders are now hypothesized to be caused 
due to a toxic gain-of-function by the corresponding RNA transcripts (72-75).   
Friedreich’s ataxia caused by the expansion of a GAA•TTC repeat in intron 1 of 
the frataxin gene (76-78) is one of the triplet repeat disorders that does not exhibit 
anticipation, a characteristic of most of the other TRS diseases.  The GAA•TTC 
expansion leads to insufficient production of the frataxin protein resulting in the 
accumulation of iron in the mitochondria, eventually causing neuronal death (79-81).  
Thus, the pathogenesis for each of the disorders in this category depends on a loss of 
function mutation for the protein or a toxic gain-of-function for the RNA transcript.   
 
D.  Types of genetic instability 
 Studies in several different systems including bacteria, yeast, mice as well as a 
number of eukaryotic cells in culture have investigated the ability of the triplet repeat 
sequences to either expand or delete in these models.  These studies have been extremely 
useful in understanding the complex mechanisms and the array of factors involved in the 
genetic instability associated with the human disease [reviewed in (5-7,38)].  In addition 
to the expansions and deletions, similar to those observed in the human diseases, a 
number of other types of instabilities including small slipped-register instabilities, 
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tandem duplications and gross deletions/rearrangements have been observed in the 
various model systems and are discussed below.   
 1.  Large expansions and deletions.  The expansions of the repeat sequences 
result in the manifestation of the disease phenotype in humans.  The repeats can expand 
to a premutation size and then into the full mutation in subsequent generations.  These 
expansions are characteristic of these diseases and constitute the predominant type of 
instability in humans (5).  Several model systems used to study the mechanisms of 
genetic instability have generated both expansions and deletions.  Deletions of the 
expanded tracts (also called reverse mutations) have been documented for several triplet 
repeat disorders in humans.  A number of cases of DM1 have shown a reduction in the 
number of repeats in transmission from an affected parent to offspring (82-86).  Repeat 
deletions in sperm have also been observed for both FRDA (87) as well as SBMA (88).  
Additionally, CGG•CCG tract deletions have been found within or around the folate-
sensitive fragile sites (89,90).  Several cis-elements including repeat length, repeat 
purity, proximity to the origin of replication, direction of replication and chromosomal 
location have been implicated to play an important role in explaining the bias of 
expansions to deletions in humans.  Moreover, several trans-factors such as various 
repair and replication proteins may act in concert with the cis-elements to enhance repeat 
instability (4).   
 2.  Small slipped-register instabilities.  Small expansions and deletions (in 3 
base pair registers) were studied in vivo in E. coli (91).  These studies revealed for the 
first time that large and small expansions and deletions occurred via different 
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mechanisms.  A model involving strand misalignment, incision or excision followed by 
DNA synthesis and ligation was proposed to explain small slipped expansions and 
deletions (SSED) (91).  The small slippage events were considered to be substrates for 
methyl-directed mismatch repair (MMR) and nucleotide excision repair (NER).  This 
mechanism was proposed to explain the small expansions associated with the type I 
hereditary neurological diseases.   
 3.  Tandem duplications.  This form of triplet repeat instability was observed in 
E. coli, in which the entire block of repeats as well as 129 base pairs (bp) of non-
repetitive flanking sequence was duplicated (92).  The products from this duplication 
contained as many as 34 repeat units.  This duplication required the presence of two or 
more TRS containing units in close proximity (170 bp) to the R6K γ origin of 
replication.  The mechanism proposed to explain these duplications involved secondary 
structure formation, stalling of DNA synthesis and the slippage-mediated misalignment 
of complementary strands during DNA replication.   
 4.  Gross deletions/rearrangements.  Recently a new type of instability has 
been associated with triplet repeat sequences studied in E. coli.  This instability is termed 
gross deletions/rearrangements wherein, a deletion occurs not only within the repeat 
tract but also in the region flanking the repeats (7,93).  Studies using the CTG•CAG 
tracts showed that the presence of long tracts of the repeats promoted formation of 
inversions and long deletions that removed part or all of the repeats as well as the 
flanking green fluorescent protein (GFP) reporter gene (93).  Shorter repeat lengths, as 
well as the GAA•TTC repeats were inert.  The potential for the triplet repeats to be 
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mutagenic was investigated after observations of rearrangements occurring within the 
2.5 kbp (purine – pyrimidine) tract from the human polycystic kidney disease 1 (PKD1) 
gene (94).  These studies proposed the formation of alternative DNA structures to trigger 
genomic rearrangements by activation of the recombination-repair pathways (95,96).  
Similar to the PKD1 studies, the gross deletions associated with the DM1 sequence were 
predicted to be formed due to the presence of non-B DNA folded conformations found at 
or near the breakpoints for all rearrangements (93).  Additionally, long CTG•CAG 
repeats were shown to induce deletions and rearrangements as a result of recombination 
at the adenine phosphoribosyltransferase (APRT) locus in Chinese hamster ovary (CHO) 
cells (97), further supporting the mutagenic role of the trinucleotide repeats.   
 
E.  Mechanisms involved in genetic instability 
 There are a number of mechanisms that work in concert with each other and 
contribute to the genetic instabilities of the triplet repeat disorders.  The most important 
mechanisms include replication, repair, recombination, and transcription.  The 
propensity of the various repeating sequences to form non-B DNA structures is believed 
to be involved in all of the mechanisms generating instabilities.  In individuals with these 
hereditary neurological diseases, the expansions are locus-specific (4,5).  However, 
tissue-specific somatic instability is observed in some cases (98-103).  This somatic 
instability has been observed in both proliferating as well as non-proliferating tissues 
(99,104-106).  A number of mechanisms have been implicated to influence repeat 
instability; these mechanisms can either work in concert with each other or may 
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represent conditions in a certain tissue, or at a particular locus, or even a specific stage of 
development.   
 1.  Non-B DNA Structures.  The repeating sequences associated with 
neurological diseases have been shown to form several secondary structures.  These 
structures include hairpins, slipped-strand DNA, triplexes, tetraplexes, DNA unwinding 
elements (DUE’s) and sticky DNA (Fig. 2).  The various mechanistic models proposed 
to explain genetic instability implicate the formation of folded-back structures by the 
repeating sequences [reviewed in (4-7,38)].   
The simplest structure that seems to be formed by a large number of repeating 
sequences is a hairpin-loop (Fig. 2A).  A hairpin structure is formed by the folding back 
of single-stranded DNA on itself.  Several biophysical, biochemical and theoretical 
experiments have shown the CTG, CAG, CGG, CCG, GTC, GAC, GAA, TTC, and 
CAGG strands, to all form hairpin structures (107-120).  The stability of each of these 
hairpins varies depending on the stability of the mispairs within the structure.  
Additionally, the stability of the mispairs is sequence context dependant wherein, the 
nearest neighbor flanking the mismatch infuences its stability in a given non-B DNA 
structure (121-127).  An order of stability for the DM1 and FRAXA sequences, CGG > 
CTG > CAG > CCG was established using CD, optical melting, differential scanning 
and calorimetry (112).  This variation in the stabilities of the structures formed by each 
of the repeating sequences can potentially explain a strand bias, where one strand in a 
DNA duplex would be more likely to form a stable secondary structure as compared to 
its complement.  This strand bias (differences between orientations I and II) was 
 11
 
 
 
                    FIG. 2.  Non-B DNA structures formed by repeating sequences.   
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observed in a number of experiments in E. coli, yeast as well as tissues culture models 
(120,128-137).  Long CTG•CAG and CGG•CCG repeats form slipped-strand DNA (in 
vitro), where hairpins are formed on both the complementary strands (138-140).  This 
occurs when the two strands are allowed to denature and are then re-annealed.  
Furthermore, studies conducted on hairpin/slipped structures have shown several repair 
proteins, such as UvrA and MSH2 to bind to them (141,142).   
 In addition to hairpins the CGG repeats associated with the Fragile X syndrome 
were hypothesized to form tetraplexes (143-145) (Fig. 2B).  These tetraplexes occur at 
G-rich sequences such as telomeric DNA where the G-residues form a G-quartet 
(146,147).  These structures can either be unimolecular or can result from the interaction 
between two hairpins (143-145).  Tetraplexes occurring at the CGG•CCG repeats are 
believed to be responsible for the replication pausing observed in vitro which can be 
alleviated by addition of a helicase that unwinds the structure.  These studies proposed 
that quadruplexes could potentially exist in vivo and contribute to the instability 
observed in the Fragile X syndrome (148-151).  However, recent experiments by Fojtik 
et al. showed the reluctance of these repeats to form tetraplexes at physiological 
concentrations of sodium and potassium ions.  These results revealed the improbability 
of the formation of tetraplexes by the CGG repeats in vivo (152).   
 Triplexes (Fig. 2C) are formed at long runs of polypurine•polypyrimidine mirror 
repeat sequences where the purine strand in a duplex DNA, Hoogsteen base pairs with a 
second purine or pyrimidine strand of another duplex to result in a three strand 
interaction (7,153-155).  The GAA•TTC repeats associated with Friedreich’s ataxia have 
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been shown to form both inter as well as intra-molecular triplexes (155-157).  
Additionally, the CTG•CAG and CGG•CCG repeats were postulated to from triplex 
DNA (158).  Recently, a novel structure termed “sticky DNA” was proposed where two 
long tracts of GAA•TTC repeats within the same molecule associate with each other to 
form a dumbbell shaped conformation in bacterial plasmids (7,154,159) (Fig. 2D).  
Although the exact conformation of sticky DNA is not clearly elucidated, it has special 
requirements for formation and once formed does not dissociate easily (7,154,159,160).  
This structure has been implicated in the decrease of the recombination hotspot activity 
of the GAA•TTC repeats (161). 
 The pentanucleotide repeat sequence associated with spinocerebellar ataxia type 
10 (SCA10) has recently been shown to be a DNA unwinding element (DUE) (41,162).  
DUE’s are A+T rich sequences commonly found at replication origins (153) (Fig. 2E).  
The ATTCT•AGAAT sequence shows a high propensity to unwind and can act as an 
aberrant DNA origin.  The DNA unwinding characteristic of this sequence and its 
function as an aberrant origin may contribute to the instability associated with the repeat 
tract (162). 
The formation of all of these folded-back structures have been implicated in 
replication pausing, recombination-repair, generation of double-strand breaks (DSBs) 
and transcription inhibition [reviewed in (4,6,7)].   
 2.  Replication.  The first factor to be implicated in repeat instability, early in the 
history of triplet repeat disorders, was replication-slippage (128).  Repeat instability was 
observed in, but not limited to, highly proliferative cells and during embryogenesis and 
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fetal development (100,106,163,164).  Additionally, an orientation bias obtained in 
studies conducted in E. coli as well as yeast systems further implicated a slippage 
mechanism (128,130,131,133,135,136,165).  The bias was attributed to the propensity of 
one of the two complementary strands of the repeat tract to form stable secondary 
structures.  In the case the structure formed on the template strands, the subsequent 
daughter strands would be deleted.  However, if slippage occurred on the nascent (newly 
synthesized) strand then an expansion would ensue.  Recent studies on CTG•CAG and 
CCTG•CAGG repeats in COS cells, have shown similar results to those obtained in 
bacterial and yeast models (120,137).   
Most models have proposed a greater opportunity for slippage and structure 
formation on the discontinuously synthesized daughter strand, due to its single-stranded 
nature as compared to the continuously synthesized leading strand.  Thus, Okazaki 
fragment maturation has gained a lot of interest in recent years.  The location of 
initiation of the Okazaki fragments within the repeat tract was proposed to influence 
repeat stability (4,120,137).  Also, the human flap endonuclease 1 (FEN-1 and Rad27 in 
yeast) was shown to destabilize the repeats as a result of the abberant 5`-end processing 
of the Okazaki fragments by FEN-1/Rad27 (166-171).  Mutations in FEN-1/Rad27 lead 
to expansions and this behavior was attributed to the ability of the 5` flaps to fold back 
into secondary structures that could not be processed by FEN-1/Rad27.  The subsequent 
re-annealing of these unprocessed adjacent Okazaki fragments would lead to the 
observed expansions (165,166,168).  These studies with flap processing have been 
conducted in bacteria and yeast cells.  In mammals a complete loss of FEN-1 results in 
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embryonic lethality (172).  However, transgenic mice either heterozygous or 
homozygous for FEN-1 were created harboring the HD CAG•CTG repeat sequence 
(173).  The heterozygous mice showed an intergenerational instability of the repeats 
when compared to the homozygous wild-type mice.  These results along with studies in 
human cell lines deficient in FEN-1 that gave rise to instability (173), substantiate the 
protective function of FEN-1 in repeat tract expansions.   
In vitro studies using human, bacterial and phage polymerases 
(115,148,151,174,175) have shown both the CTG•CAG and the CGG•CCG repeats to 
cause a length-dependent replication pausing.  Two-dimensional gel electrophoresis was 
used to demonstrate the accumulation of replication intermediates in E. coli (176).  
These studies implicated a length and sequence-dependent slowing or pausing of the 
replication fork that occurred specifically within the CTG•CAG and CGG•CCG triplet 
repeats.  The pausing was dependent on the orientation, where the more stable structure-
forming sequences, CTG and CGG, caused a more pronounced pausing effect than the 
complementary CAG and CCG repeats.  Consistent with the bacterial data, studies 
conducted in vivo in yeast also showed replication pausing for CTG•CAG, CGG•CCG as 
well as the GAA•TTC repeat tracts (177,178).  The pausing of the replication fork at 
these repeats was hypothesized to lead to the formation of double strand breaks (DSBs), 
the repair of which could lead to instability.   
In addition to the direction of replication fork progression, Okazaki fragment 
maturation, and polymerase pausing, studies have revealed that the distance of the 
repeats from the replication origin also influences genetic instability (120,137). Repeats 
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cloned proximal to the origin were more unstable as compared to repeats cloned distal to 
the same origin.  Also, studies conducted using mutants of DNA polymerases (179-183), 
proteins involved in lagging strand maturation and processing (179,183-187), and single-
strand binding protein (188) have revealed a role for all of these proteins in promoting 
genetic instabilities.   
3.  Recombination.  The formation of double strand breaks (DSBs) is thought to 
occur when the replication fork is challenged by the non-B DNA structures formed by 
the repeating tracts.  Additionally, the repair of these structures may also result in DSBs 
or nicks within the repeats (4,6,189).  The repair of the breaks occurs by a recombination 
mediated mechanism.  Initial models of recombination based genetic instability were not 
supported by observations in humans, as recombination was defined as reciprocal 
crossing-over between sister or homologous chromosomes (45,190-192).  However, data 
from patients implicated a gene-conversion (non-reciprocal) event (137,193).  Therefore, 
DSB repair and recombination via gene conversion is proposed as another mechanism 
that might generate the genetic instability of trinucleotide disorders.   
 Recent studies using long CTG•CAG repeat tracts (up to 250 repeats), showed 
the induction of DSB repair and recombination on the yeast chromosome (165).  
However, previous work (136,170,179) in yeast model systems were unable to show this 
effect, and it was thought that the shorter repeat lengths used in these studies may not be 
efficient in generating DSBs, or that breaks that were indeed induced were repaired by a 
mechanism other than homologous recombination (HR).  Freudenreich et al. determined 
that the CTG•CAG tracts present on the yeast chromosome induced DSBs in a length-
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dependent manner (165).  Additionally, expansions occurred at a higher frequency 
during meiosis when compared to similar constructs replicated in mitosis (194-198).  
The meiosis specific endonuclease SPO11 created DSBs, the repair of which lead to the 
instability of the CTG•CAG tracts (198).  DSBs were also artificially induced in yeast in 
vivo by using the homing endonuclease, I-SceI (199).  This work implicated long lengths 
of the CTG•CAG tracts to induce gene conversion mediated expansions.  A synthesis-
dependent strand annealing (SDSA) pathway, following DSBs, was proposed to explain 
both the meiosis and mitosis based gene conversion events leading to instability (200).   
 Studies in E. coli have also proposed recombination-mediated repair of DSBs as 
a plausible mechanism for the generation of large expansions associated with the 
repeating disorders.  A gene conversion mechanism was first proposed to explain the 
expansions of the CTG•CAG repeats in an intermolecular assay (193).  Another set of 
studies using both intermolecular and intramolecular assays, further showed a 
stimulation of the frequency of crossing-over between long tracts of CTG•CAG repeats 
(201,202).  Similar work with the GAA•TTC repeats associated with Friedreich’s ataxia 
showed these repeats to be recombination hotspots (161) however, the formation of 
sticky DNA reduced the hotspot activity of these repeats.  Recent work on the 
CCTG•CAGG tetranucleotide repeats have also implicated a recombination-repair 
mechanism to generate the observed expansions (R. Dere and R. D. Wells, manuscript in 
preparation).  Additionally, the transformation of break containing plasmids harboring 
several different lengths of the CTG•CAG repeats into E. coli showed a pronounced 
effect of the break on the stability of the repeats (203).  Another genetic assay to 
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measure recombination rates revealed that mutations in recA and recB had a stabilizing 
effect on the CTG•CAG sequences (204).  The stabilization was measured as a reduction 
in the amount of deletions obtained as a result of recombination.   
 The involvement of recombination-repair in mammalian systems has only 
recently been investigated.  Studies in CHO cells revealed a role for long CTG•CAG 
tracts to influence recombination between two copies of the APRT gene (97).  The rate 
of gene conversion was 3 – 4 fold lower and the rate of crossing-over was 2 – 3 fold 
higher when compared to the controls lacking the repeats.  In another study, DNA breaks 
were artificially introduced into CTG•CAG tracts before transfection into COS-1 cells 
(205).  The repair of these breaks yielded deletion products, which were attributed to 
formation and subsequent repair of secondary structures at the repeats.  A DM1 mouse 
model was used to show the involvement of the single-strand annealing pathway in the 
CTG•CAG repeat instability in mice (206).   
 4.  Repair.  The errors introduced in the DNA, due to the presence of the triplet 
repeats, can be repaired by a variety of cellular pathways.  Expansions of the repeat 
sequences could occur either due to a lack of repair function or even during the repair 
process itself.  Several proteins from major repair pathways including methyl-directed 
mismatch repair (MMR) and nucleotide excision repair (NER) have been implicated in 
triplet repeat stability.  Recently, the SbcCD and MRX complexes from E. coli and 
yeast, respectively have also been shown to prevent the expansions of the CTG•CAG 
tracts (207,208).  Both of these complexes have been implicated in hairpin excision both 
in vitro and in vivo (209-212).   
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 A number of experiments have been conducted to evaluate the role of MMR in 
trinucleotide repeat instability.  Since the triplet repeats can form non-B DNA structures, 
especially hairpin loops and slipped-strands, the mismatches in the stem of the hairpins 
could lead to activation of the MMR pathway.  Initial experiments revealed that 
mutations in the MMR proteins did not influence long tract changes but only caused 
small expansions and deletions (1 – 2 repeats) (91,213-217).  Similar results were also 
observed in yeast (165,170,218-220).  However, another set of experiments with pure 
tracts of CTG•CAG showed no influence of MMR on genetic instability (214).  These 
inconsistencies were resolved a few years later when the length and sequence purity of 
the repeat tracts was proposed to affect the role of MMR in instability and the kind of 
instability (small expansions vs. large expansions) obtained (215,216).  Studies in 
transgenic mice have revealed that the small expansions of the CAG•CTG repeats 
observed in HD mice require the presence of the MSH2 gene (192,221).  The expansions 
were proposed to occur either due to the recognition and binding of the MSH2 to the 
small loops formed by the repeats thus protecting them from excision or due to the repair 
of the loops by the MMR pathway.  Recently, a deletion of Msh3 but not Msh6 was 
found to repress somatic expansions in a DM1 knock-in mouse (222).  The Msh2/Msh3 
complex was proposed to be acting on the triplet repeats in the DM1 mice leading to the 
somatic instability.  Additional support for the involvement of MMR in triplet repeat 
instability came from studies in which a MutL homologue, Pms2, was shown to be a 
genetic enhancer of CTG•CAG repeats in somatic mosaicism (223).   
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 Another repair pathway that could be involved in triplet repeat instability is NER.  
The NER pathway is known to recognize damage that causes distortions in the DNA 
duplex.  Secondary structures formed by the repeating sequences could thus be potent 
inducers of NER.  Parniewski et al. showed that mutations in the UvrA protein increased 
the instability of the CTG•CAG tracts (but not the GAA•TTC and CGG•CCG repeats) 
compared to strains that carried mutations in UvrB (and an active UvrA) (224).  These 
instabilities were further enhanced in the presence of transcription.  In contrast another 
study showed a stabilization of the repeats in the absence of the UvrA protein (142).  
Furthermore, UvrA was shown to bind loops of 1, 2 or 17 CAG repeats in vitro.  
Although experiments in bacteria have implicated a role for NER in genetic instability, 
studies in yeast cells showed that the deletion of Rad1 (involved in NER) did not 
stimulate any instability (165).  Thus, additional work would have to be conducted 
before the NER pathway can be implicated conclusively in repeat instability. 
 5.  Transcription.  Transcription is another factor that has been investigated as a 
potential mechanism of repeat instability.  Bowater et al. showed that transcription 
destabilized the CTG•CAG repeats in E. coli (225).  The repeats were found to be 5 – 20 
fold more stable in the absence of active transcription.  Another set of experiments 
showed that the NER pathway influenced the stability of the DM1 sequence in 
transcribed plasmids (224).  These results indicated the involvement of repair during 
transcription as a plausible mechanism of genetic instability.  Moreover, studies 
modulating transcription through plasmids harboring the GAC•GTC repeats implicated 
transcription as a mechanism to generate large deletion events whereas small deletions 
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and expansions were attributed to replication-slippage (226).  An in vitro transcription 
system was used to show a sequence specific pausing of RNA polymerase II through 
CTG, CAG, CGG and CCG repeats (227).  More recently, the effect of transcription on 
the genetic instability of the tetranucleotide CCTG•CAGG repeats was analyzed.  
Transcription was once again shown to influence the instability both in COS-7 cells and 
E. coli (R. Dere and R. D. Wells, manuscript in preparation).   
 
F.  Non-triplet repeat disorders 
 The expansions of repeats within the coding or non-coding region of a gene have 
been associated with several neurological diseases.  Most of these disorders are caused 
by trinucleotide repeat sequences with the exception of three diseases caused by non-
triplet sequences including a tetranucleotide, a pentanucleotide and dodecamer repeat 
sequences.  The dodecamer sequence was found to be associated with progressive 
myoclonus epilepsy 1 (EPM1) (also called Unverricht-Lundborg disease), the 
pentanucleotide repeat, and the tetranucleotide repeat were associated with SCA10 and 
DM2, respectively.  The dodecamer and pentanucleotide repeat disorders are described 
in this section whereas, the tetranucleotide repeat disease (DM2) has been described in 
the following section as it is the repeat sequence that is the focus of this dissertation.   
 1.  Progressive myoclonus epilepsy 1.  The Unverricht-Lundborg disease is an 
autosomal recessive neurological disorder caused by the expansion of a dodecamer 
sequence (CCCCGCCCCGCG•CGCGGGGCGGGG) in the 5` flanking region of the 
cystatin B (CSTB) gene (228).  Normal alleles contain either 2 or 3 repeats whereas the 
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alleles of affected patients contain approximately 30 to 80 copies of the repeat (228-
230).  There does not seem to be any correlation between the age of onset and the 
severity of the disease (anticipation).  The repeat expansion results in a marked decrease 
in the expression levels of CSTB.  Studies have suggested a role for CSTB in the 
maintenance of normal neuronal structure however the relationship between the loss of 
CSTB and the EPM1 phenotype is still unclear.  The mechanisms of repeat expansions 
in this disease are believed to be similar to the mechanisms for trinucleotide repeat 
expansions which include the proteins involved in replication and recombination (40).  
Additionally, the dodecamer repeat sequence has been shown to form secondary non-B 
DNA structures (231-234) that have been implicated in repeat instability.   
 2.  Spinocerebellar ataxia type 10 (SCA10).  SCA10 is an autosomal dominant 
disorder characterized by ataxia, and seizures.  It is caused by the expansion of a 
pentanucleotide ATTCT•AGAAT repeat tract in intron 9 of a novel gene termed SCA10 
(235).  Normal individuals carry 10 – 22 uninterrupted ATTCT•AGAAT repeats and are 
predominantly heterozygous, whereas patients with SCA10 exhibit a loss of 
heterozygosity and carry expansions between 800 – 4000 repeats (41,235).  Currently, 
the exact genetic or biochemical functions of the SCA10 gene are unknown however, 
this protein is expressed at high levels in the brain.  The possible mechanism in SCA10 
pathogenesis is hypothesized to be either a genomic disruption (alterations in chromatin 
structure) due to the large size of the repeat tract, an RNA gain-of-function as observed 
for DM1 and DM2 or simply a SCA10 loss-of-function (41).  The structural properties 
of these pentanucleotide repeats were studied in plasmids and the results indicated that 
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the repeat containing strands of the DNA remained unpaired, and this unpaired structure 
functioned as an aberrant origin of replication in HeLa cell extracts (162).   
 
G.  Myotonic dystrophy type 2 
 Myotonic dystrophy type 2 (DM2) is caused by a CCTG•CAGG tetranucleotide 
repeat expansion in intron 1 of the zinc finger protein 9 (ZNF9) gene located on 
chromosome 3q (236).  The clinical presentation of this neurological disease is strikingly 
similar to that of myotonic dystrophy type 1 (DM1), including myotonia, proximal 
weakness, frontal balding, cardiac arrhytmias, insulin-resistance associated diabetes 
mellitus, polychromatic cataracts and infertility (42,237).  Although, the tetranucleotide 
repeat is dominantly inherited, DM2 patients with two mutant alleles were not reported 
until recently where, three homozygotes were found in a large consanguineous family 
from Afghanistan (238).   
1. Historical perspective.  In 1994, patients showing clinical similarity to DM1 
but without a dystrophia myotonica protein kinase (DMPK) gene mutation were 
described (239,240).  This condition was termed proximal myotonic myopathy 
(PROMM) and showed features of proximal weakness, cataracts and myotonia in the 
presence of a normal DMPK gene.  Furthermore, in 1997, a Finnish family with 
PROMM and hearing loss, muscular dystrophy and hypogonadism was described and 
this condition was termed proximal myotonic dystrophy (PDM) (241).  In 1998, further 
evidence for the clinical heterogeneity of non-DM1 myotonic dystrophy was provided to 
describe a large Minnesota kindred with distal weakness (242).  This condition was 
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termed dystrophia myotonica type 2 (DM2).  However, all three conditions of PROMM, 
PDM and DM2 were finally mapped to the same locus on chromosome 3 a year later 
(243,244).  In 2001, Liquori et al. detected an unstable CCTG•CAGG repeat expansion 
to be responsible for DM2 (236).  The CCTG•CAGG repeat tract is part of a complex 
motif with the overall configuration (TG•CA)n(TCTG•CAGA)n(CCTG•CAGG)n.  The 
expanded allele sizes ranged from 75 to 11,000 repeats, averaging at 5000 repeats.  The 
largest normal allele was sequenced and shown to contain 26 repeats with two 
interruptions.  However, the time-dependent somatic instability associated with this 
disease complicates the correlation of repeat length with the age of disease onset 
(anticipation) and the estimation of the smallest pathogenic size (236).   
2. RNA pathogenesis.  The CCTG•CAGG repeat expansion is located in intron 
1 of the ZNF9 gene.  This gene is highly expressed in the heart and skeletal muscles, the 
two tissues most affected in DM2 (42).  The transcribed ZNF9 mutant RNA accumulates 
in numerous nuclear foci, similar to the mutant DMPK RNA foci observed in DM1 
(236).  Recent studies have revealed that the expanded mutations in both DM1 and DM2 
exert their deleterious effects at the RNA level.  The CUG (in DM1) and CCUG (in 
DM2) containing transcripts are thought to alter the regulation and localization of certain 
CUG-binding proteins (72,245-247).  The CUG-BP (CUG binding protein) which is 
over-expressed in the myotonic dystrophies was shown to bind single-stranded CUG in 
vitro (72,248) but failed to co-localize with the ribonuclear foci (249,250).  On the other 
hand, three muscleblind proteins – MBNL, MBLL and MBXL (homologues of the 
Drosophila muscleblind protein) co-localize with the nuclear foci (246,250,251).  The 
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sequestration of these RNA-binding proteins is causative of dysregulation of alternative 
downstream splicing that has been shown to be characteristic of both DM1 and DM2.  It 
is currently believed that the antagonistic effects of the increase in CUG-BP (which 
promotes the inclusions of exons normally favored during fetal development) and the 
depletion of the muscleblind proteins (which normally favor splice forms expressed in 
adults) affects alternative splicing (246,247).  However, studies are still underway to 
establish a better understanding of the molecular mechanism of this RNA gain-of-
function pathway.   
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CHAPTER II 
HAIRPIN STRUCTURE-FORMING PROPENSITY OF THE 
CCTG•CAGG TETRANUCLEOTIDE REPEATS CONTRIBUTES TO THE 
GENETIC INSTABILITY ASSOCIATED WITH MYOTONIC DYSTROPHY 
TYPE 2* 
 
A.  Overview 
The genetic instabilities of (CCTG•CAGG)n tetranucleotide repeats were 
investigated to evaluate the molecular mechanisms responsible for the massive 
expansions found in myotonic dystrophy type 2 (DM2) patients.  DM2 is caused by an 
expansion of the repeat from the normal allele of 26 to as many as 11,000 repeats.  
Genetic expansions and deletions were monitored in an African green monkey kidney 
cell culture system (COS-7 cells) as a function of the length (30, 114 or 200 repeats), 
orientation, or proximity of the repeat tracts to the origin (SV40) of replication.  As 
found for CTG•CAG repeats related to DM1, the instabilities were greater for the longer 
tetranucleotide repeat tracts.  Also, the expansions and deletions predominated when  
 
——————— 
* Reproduced with permission from “Hairpin Structure-forming Propensity of the CCTG•CAGG 
Tetranucleotide Repeats Contributes to the Genetic Instability Associated with Myotonic Dystrophy Type 
2” by Ruhee Dere, Marek Napierala, Laura P. W. Ranum and Robert D. Wells (2004) Journal of 
Biological Chemistry, Volume 279, 41715 – 41726.  Copyright © 2004 by The American Society for 
Biochemistry and Molecular Biology, Inc. (See Appendix) 
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cloned in orientation II (CAGG on the leading strand template) rather than I and when 
cloned proximal rather than distal to the replication origin.  Biochemical studies on 
synthetic d(CAGG)26 and d(CCTG)26 as models of unpaired regions of the replication 
fork revealed that d(CAGG)26 has a marked propensity to adopt a defined base paired 
hairpin structure whereas the complementary d(CCTG)26 lacks this capacity.  The effect 
of orientation described above differs from all previous results with three triplet repeat 
sequences (TRS) (including CTG•CAG) which are also involved in the etiologies of 
other hereditary neurological diseases.  However, similar to the TRS, the ability of one 
of the two strands to form a more stable folded structure, in our case the CAGG strand, 
explains this unorthodox “reversed” behavior.   
 
B.  Introduction 
Myotonic dystrophy type 2 (DM2) is a dominantly inherited neurological disease 
caused by the expansion of a CCTG•CAGG tetranucleotide repeat in intron 1 of the zinc 
finger protein 9 (ZNF9) gene (236).  The characteristics of DM2 are very similar to 
those observed for DM1 and include myotonia, proximal weakness, frontal balding, 
cardiac arrhythmias, insulin-resistance associated diabetes mellitus, polychromatic 
cataracts and infertility (42,252-255).  The largest normal allele was found to contain 26 
CCTG•CAGG repeats, whereas the repeats were expanded to 75 – 11,000 (average of 
5,000 repeats) in patients (236).  This is the largest known repeat expansion associated 
with a disease; also, it is the first tetranucleotide repeat to be implicated in a hereditary 
neurological disease.   
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At least 15 hereditary neurological diseases (i.e. myotonic dystrophy, Fragile X 
syndrome and Friedreich’s ataxia) are associated with the expansions of (CTG•CAG)n, 
(CGG•CCG)n or (GAA•TTC)n repeat tracts, respectively (4,5,37,38,189,256,257).  
Additionally, two other non-triplet repeat neurological diseases, spinocerebellar ataxia 
type 10 (SCA10) (235) and progressive myoclonus epilepsy of Unverricht-Lundborg 
type (EPM1) (228), are caused by the expansions of pentanucleotide and 
dodecanucleotide repeating sequences, respectively.   
 Replication (5,38,128,130,131,137,165,174,176,177), recombination 
(161,193,201,202,258), and repair (38,165,205,213) were shown to be responsible for 
the instabilities of triplet repeat sequences (TRS).  Slippage of the repeats (259-262) as 
promoted by non-B DNA structures (5,38,114,257,263,264) formed by these repeating 
sequences causes polymerases to pause during replication, as shown both in vivo as well 
as in vitro (115,117,129,148,174,176,178,265), thereby generating instabilities.  
Furthermore, these structures are also recognized by mismatch repair (MMR) 
(91,141,213,214,219,266) and nucleotide excision repair (NER) (142,224); both 
pathways have been implicated in the stability of the secondary structures, thus 
influencing the expansion and deletion processes.  Also, double-strand breaks (DSB) 
caused by replication fork arrest or repair of the non-B DNA structures induces repair-
mediated recombination which may participate in the expansions observed in both 
prokaryotic as well as eukaryotic model systems (136,165,196,203,205,267-269).  
Triplet repeat sequences are hotspots for recombination, which may account for the 
massive expansions found in certain diseases (161,193,201,202,258,270,271).   
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Herein, we show that the repeating tetranucleotide genetic instabilities associated 
with DM2 are caused by a structure-mediated replication-based slippage mechanism.  
The difference in the propensities of the CAGG and CCTG strands to transiently form 
quasistable DNA hairpin structures determines the type and level of instability.  
Furthermore, this instability is influenced by the length, orientation and position of the 
repeats with respect to the origin of replication.   
 
C.  Experimental procedures 
Construction of the (CCTG•CAGG)n Containing Shuttle Vector – The 
CCTG•CAGG tetranucleotide repeats (236) were obtained from three pCR2.1TOPO 
derivatives containing either 30, 114 or 200 repeats.  All three (CCTG•CAGG)n inserts 
(where n = 30, 114 or 200) were excised from their respective pCR2.1TOPO derivative 
plasmids using either an EcoRV/EagI digest or an EcoRI digest (all enzymes used in this 
study were purchased from New England Biolabs, Inc.).  The CCTG•CAGG inserts are 
flanked on either side by vector sequences and lack any flanking non-repetitive human 
DM2 sequences.  On excising the inserts using the EcoRV/EagI digest, in addition to the 
30, 114 and 200 repeats there are 21 bp of vector flanking sequences on the EcoRV side 
of the insert and 24 bp of vector flanking sequence on the EagI side.  The EcoRV/EagI 
fragments were filled-in using 1 unit of the Klenow fragment of E. coli DNA polymerase 
I (U.S.Biochemical Corp.), purified on a 5.5% polyacrylamide gel in TAE buffer (40mM 
Tris acetate, 1mM EDTA, pH 8) and blunt-end ligated into the SmaI site of pCDNA3.1 
(Invitrogen).  Alternately, the (CCTG•CAGG)n tracts were excised using an EcoRI 
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digest, purified on a 5.5% polyacrylamide gel and ligated into the MfeI site of the same 
shuttle vector.  This fragment had 11 bp of pCR2.1TOPO vector flanking sequence on 
one side and 9 bp of vector flanking sequence on the other side of the repeating tract.  
The ligations were performed at 16°C for 16 h by the addition of 20 units of T4 DNA 
ligase (U.S.Biochemical Corp.) in the presence of 1mM ATP followed by transformation 
into E. coli HB101 (New England Biolabs, Inc.) (F- ∆(gpt-proA)62, leuB6, glnV44, 
ara14, galK2, lacY1, ∆(mcrC-mrr), rpsL20 (Strr), xyl5, mtl-1, hsdS20 (rB-, mB-), recA13) 
and plated on LB plates containing ampicillin (100 µg/ml).  Individual colonies were 
grown in LB broth containing ampicillin (100 µg/ml) for 16 h at 37°C.  Plasmids were 
isolated using the alkaline lysis procedure (Promega, Wizard Plus Miniprep DNA 
Purification System).   
 The plasmids carrying the (CCTG•CAGG)n inserts were characterized using 
restriction mapping and DNA sequencing.  An EcoRI digest was used for repeat tracts 
cloned proximal (SmaI site) to the SV40 origin of replication and an AflIII/BglII digest 
was used for inserts cloned into the site distal (MfeI site) to the same origin of 
replication.  The restriction fragments were end-labeled with [α-32P] dATP and 1 unit of 
the Klenow fragment of E. coli DNA polymerase I and analyzed on 5.5% 
polyacrylamide gels.  Furthermore, the plasmids containing the (CCTG•CAGG)n repeats 
were dideoxy sequenced on both strands to determine the length, purity and orientation 
of the repeats with respect to the origin of replication.  The sequencing reactions were 
performed using the Thermo Sequenase Radiolabeled Terminator Cycle Sequencing Kit 
(U.S.Biochemical Corp.) according to the manufacturer’s recommendations.  The 
 31
products of the sequencing reactions were analyzed on 6% Long Ranger gels (FMC 
BioProducts) containing 7.5M urea in the glycerol tolerant gel buffer (1.78M Tris, 
0.57M taurine and 0.01M EDTA) (U.S.Biochemical Corp.).  The (CCTG•CAGG)30 is a 
pure repeat (i.e. it contains no polymorphisms/interruptions) as determined by 
sequencing of the entire repeat containing tract.  The (CCTG•CAGG)114 and the 
(CCTG•CAGG)200 carried a single bp interruption 11 repeats into the tract to give the 
sequence (CCTG)11CCTT(CCTG)n where n = 102 and 188, respectively.  The 
(CCTG•CAGG)n (where n = 114 or 200) repeats were sequenced using primers located 
at both ends of the repeating tract.  In case of the (CCTG•CAGG)114, sequencing enabled 
the determination of  ~ 200 – 300 bps into the repeats from either side; however, on 
excising and analyzing the repeat containing fragment from the plasmid, an error of 
approximately ± 5 repeats was obtained.  Similarly, on analyzing the excised 
(CCTG•CAGG)200 fragment on polyacrylamide gels, the estimated repeat length varied 
by ± 5 repeats.  Thus, the repeat lengths were estimated by both sequencing and 
fragment analyses.  The plasmids carried the (CCTG•CAGG)n repeat tracts in both 
orientations with respect to the SV40 origin of replication.  However, the SV40 origin is 
bi-directional (272) and is the operative origin in COS-7 cells (273).  Orientation I refers 
to the orientation in which the CCTG repeats are on the leading strand template with 
respect to the SV40 origin of replication whereas the orientation in which the CCTG 
repeats are on the lagging strand template with respect to the same origin are referred to 
as orientation II.   
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Transfection of the (CCTG•CAGG)n Repeat Containing Plasmids into COS-7 
Cells – The plasmids containing the (CCTG•CAGG)n tracts were transfected into COS-7 
cells.  The COS-7 cells were grown in DMEM media (Sigma) containing 10% fetal 
bovine serum (Gibco) on 10 cm diameter plates.  The cells were 75% confluent when 
transfected with 2 µg of DNA using Lipofectamine 2000 (Invitrogen).  The COS-7 cells 
were allowed to grow for 24 h after transfection before replacing the DMEM medium.  
The cells were then cultured for either 48 h or 2 weeks after transfection.  The COS-7 
cells cultured for 2 weeks were split every 36 – 48 h when the cells were almost 100% 
confluent.  Antibiotic selection [geneticin (G418) – 400 µg/ml] (Invitrogen) was applied 
48 h after transfection and continued thereafter for the entire 2-week period.  The 
episomal DNA was isolated using alkaline lysis (Promega, Wizard Plus Miniprep DNA 
Purification System).  This episomal DNA was then cleaved with 10 units of DpnI at 
37°C for 2 h.  DpnI cleaves only DNA which is methylated at its GATC recognition site 
by the DAM methylase.  Thus, treatment of the episomal DNA preparation fragments 
only the unreplicated DNA which is methylated, leaving the newly replicated but 
unmethylated or hemimethylated DNA intact.  The effectiveness of the DpnI cleavage 
was assessed by digesting the parental plasmids with DpnI, followed by transformation 
in E. coli HB101 and plating on LB plates containing ampicillin (100 µg/ml).  The 
absence of colonies on LB plates confirmed the complete fragmentation of the plasmids 
by DpnI.  The DNA after the DpnI digestion was then further purified by phenol-
chloroform extractions and ethanol precipitation. 
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Genetic Instabilities by Individual Colony Analyses – The episomal DNA, 
obtained after transfection in COS-7 cells cultured for either 48 h or 2 weeks, was 
transformed into E. coli HB101 and plated on LB plates containing ampicillin (100 
µg/ml).  Individual colonies were then picked and grown in LB broth for 16 h at 37°C.  
The analyses of single colonies enabled the detection of individual events during 
replication of the plasmids in COS-7 cells.  The plasmids were isolated using alkaline 
lysis and the DNA analyzed by restriction mapping.  The (CCTG•CAGG)n inserts were 
excised using an EcoRI digest for plasmids carrying the repeats cloned into the SmaI site 
whereas an AflIII/BglII digest was used to excise the inserts cloned into the MfeI site.  
The restriction fragments were resolved on 5.5% polyacrylamide gels.  The genetic 
instability was measured as a change in the length of the (CCTG•CAGG)n repeat 
containing fragments when compared to the size of the insert excised from the parental 
plasmid and the 1 Kbp DNA ladder size standard (Invitrogen).  The lengths of each 
insert excised from individual colonies were determined using FluorChem version 3.04 
(Alpha Innotech Corp.).  Furthermore, ~ 20 random clones containing expansions were 
sequenced to confirm the lengths and sequences of the repeat containing inserts. 
 The genetic instability (expansions and deletions) of the (CCTG•CAGG)n repeats 
generated in COS-7 cells is calculated by subtracting the background instability of the 
repeat-containing plasmids in E. coli HB101.  The genetic instability of the parental 
plasmids was measured by transforming these plasmids into E. coli HB101 and 
analyzing individual colonies using restriction mapping.  The restriction digests used for 
these analyses were similar to those used for individual colony analyses of the episomal 
 34
DNA.  The percentage of background instability [average of two experiments for the 
three tetranucleotide lengths in both orientations (total of six experiments)] varied from 
2 to 7 % for repeats cloned proximal (SmaI site) and from 0 to 12 % for repeats cloned 
distal (MfeI site) (except for (CCTG•CAGG)200 in orientation I which was 23 %) to the 
SV40 origin (data not shown).  All statistical analyses were performed using SigmaStat 
version 2.03. 
Substrate Preparation for Chemical Modification and Enzymatic Probing – In 
order to analyze the structural features of the CCTG•CAGG repeats, we used “single 
stranded” synthetic oligonucleotides as models of unpaired regions of the duplex repeat 
sequences for chemical and enzymatic modification studies.  The individual 
oligonucleotides (Genosys), d(CCTG)26 and d(CAGG)26 were purified on a 6% 
denaturing polyacrylamide gel containing 7.5M urea in glycerol tolerant gel buffer 
(U.S.B. Corp.).  The purified oligonucleotides were labeled at the 5' end with 15 units of 
T4 polynucleotide kinase (PNK) (U.S.B. Corp.) and [γ-32P] ATP at 37°C for 1 h.  The 
labeled oligonucleotides were purified on a 6% denaturing polyacrylamide gel.  These 
purified and labeled oligonucleotides were used as substrates for the chemical and 
enzymatic probing reactions. 
Chemical Modifications and Enzymatic Probing – Three chemical probes, 
osmium tetraoxide (OsO4) (Aldrich), potassium permanganate (KMnO4) (Fisher) and 
diethyl pyrocarbonate (DEPC) (Sigma), each were used to modify the d(CCTG)26 
oligonucleotide whereas the latter two chemicals were used to modify the d(CAGG)26 
oligonucleotide.  The purified and labeled oligonucleotides (4 – 5 x 105 cpm/reaction) in 
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10mM Tris, 40mM NaCl and 10mM MgCl2 were denatured by heating at 80°C for 5 min 
followed by renaturation by gradually decreasing the temperature (2°C/min) to the 
indicated reaction temperature (274).  The chemical and enzymatic probes were then 
added along with the carrier DNA (salmon sperm DNA - 1 µg/µl) (Invitrogen). 
 The DEPC modification of the oligonucleotides was carried out in a buffer 
containing 50mM sodium cacodylate, 40mM NaCl and 10mM MgCl2 (pH 7.0) at 25°C 
for 60 min (115,275-280).  The KMnO4 reaction was performed at 20°C for 30 min in a 
buffer containing 50mM sodium cacodylate and 1mM EDTA (pH 7.0) (110,278,281-
283).  A final concentration of 8% DEPC and 0.1, 0.5 and 1mM KMnO4 was used.  The 
chemical modification with 1mM OsO4 in the presence of 1mM 2,2'-bipyridine (Sigma) 
and 150mM sodium phosphate (pH 7.8) was carried out at 5°C for 30 min 
(277,278,280,284-286).  The modified oligonucleotides were then ethanol precipitated 
and cleaved at the phosphodiester bonds using 1M piperidine (280,284,285,287,288).  A 
series of ethanol precipitations and lyophilization steps then were used to ensure removal 
of the piperidine.   
 The enzymatic probes used included S1 nuclease (289,290) (Gibco BRL), P1 
nuclease (109,110,154,278,291) (Gibco BRL) and mung bean nuclease (140,292,293) 
(New England Biolabs Inc.).  All of the enzymatic probing reactions were carried out at 
5°C for 60 min in a buffer containing 10mM Tris, 40mM NaCl and 10mM MgCl2 (pH 
7.2).  1mM ZnCl2 was included in the buffer used for the S1 nuclease reactions 
(287,290).  Concentrations ranging from 4.3 – 8.7U of S1 nuclease and 0.25 – 1.0U of 
mung bean nuclease were used in a 10µl total reaction volume.  P1 nuclease was used in 
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concentrations ranging from 0.05 – 0.25 µg/ml.  The reactions were stopped by addition 
of a urea-EDTA-dye solution (274) followed by quick freezing on dry ice. 
 The products of the chemical and enzymatic reactions were then analyzed on 
10% denaturing polyacrlyamide gels using glycerol tolerant gel buffer.  The size marker 
was prepared using the Maxam-Gilbert sequencing reaction on each of the synthetic 
deoxyoligonucleotides with DMS (Sigma) followed by piperidine cleavage 
(115,276,287).  The gels were analyzed using a Molecular Dynamics – Storm 820 
(Amersham Biosciences) phosphor-imager and quantitative analyses were performed 
using ImageQuant version 5.1.   
 
D.  Results 
Strategy of Study – The (CCTG•CAGG)n repeats were cloned either proximal 
(SmaI site) or distal (MfeI site) to the SV40 origin of replication in the pcDNA3.1 
shuttle vector (Fig. 3).  An African green monkey kidney cell culture system was used to 
determine the genetic instability of the (CCTG•CAGG)n repeats associated with 
myotonic dystrophy type 2 (DM2).  COS-7 cells were transfected with the 
tetranucleotide repeat containing plasmids (Fig. 3) and were then cultured for either 48 h 
or 2 weeks (i.e. for approximately two and fourteen cell divisions, respectively) in order 
to determine the extent of genetic instability after several rounds of replication.  The 
effects of length, orientation, and location of the repeats with respect to the origin of 
replication were determined. 
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FIG. 3.  Plasmids used in the study.  The (CCTG•CAGG)n repeats (where n = 30, 114 or 200) were 
cloned into the SmaI site (proximal to the SV40 origin of replication) or the MfeI site (distal to the SV40 
origin of replication) of pcDNA3.1 in both orientations relative to the bidirectional SV40 origin of 
replication.  Orientations I and II are defined under “Experimental Procedures”. 
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 To evaluate the effect of the length of the (CCTG•CAGG)n repeat tract on the 
genetic instability, repeats of 30, 114 or 200 CCTG•CAGG units were studied.  Previous 
studies showed a marked effect of orientation of trinucleotide repeats (CTG•CAG, 
CGG•CCG and GAA•TTC) with respect to the origin of replication (38,128-
132,134,165).  Therefore, we studied plasmids carrying the CCTG•CAGG repeats in 
both orientations.  The distance of the (CCTG•CAGG)n repeats from the origin of 
replication may also play an important role in determining the genetic instabilities of 
these repeats (R. R. Iyer and R. D. Wells, unpublished work) (137).  Thus, the repeats 
were cloned either proximal [~ 74 bp from the center of the SV40 core origin (64 bp in 
length) (294) at the SmaI site (map position 2078)] or distal [~ 1842 bp from the center 
of the same core origin of replication at the MfeI site (map position 162)] to the SV40 
origin of replication.   
Genetic Instability of the (CCTG•CAGG)n Repeats – The plasmids carrying 
either 30, 114 or 200 CCTG•CAGG repeats cloned in both orientations were transfected 
into COS-7 cells (Figs. 3 and 4) and the cells were cultured.  The episomal DNA was 
isolated using alkaline lysis and the DNA was digested with DpnI (see Experimental 
Procedures).  In order to determine the genetic instability of the episomal DNA after 48 
h cultures, Southern blot analyses were performed with the (CCTG)8 oligonucleotide as 
a probe (data not shown), which confirmed the presence of the CCTG•CAGG repeats in 
the excised fragments.  Since, no instability was observed, the more sensitive single 
colony analyses were performed.   
 39
 
 
FIG. 4.  Experimental strategy using the mammalian cell culture assay.  The (CCTG•CAGG)n tracts 
(where n = 30, 114 or 200) were cloned either proximal to the origin of replication in the SmaI site (map 
position 2078) or distal to the origin of replication in the MfeI site (map position 162) (Fig. 3).  These 
plasmids were then transfected into COS-7 cells, cultured for both 48 h and 2 weeks and the episomal 
DNA isolated using the alkaline lysis method.  The episomal DNA was digested with DpnI to fragment the 
unreplicated DNA.  The episomal DNA was transformed into E. coli HB101 and individual colonies were 
analyzed using biochemical analyses. Simultaneously, plasmids that were not replicated in COS-7 cells 
were also transformed into E. coli HB101 and individual colonies were subjected to similar biochemical 
analyses (see Experimental Procedures).   
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 The episomal DNA after treatment with DpnI from 48 h and 2 week cultures was 
transformed into E. coli HB101 and DNA from individual colonies was analyzed by 
restriction digestion and the products of cleavage were analyzed in high-resolution 5.5% 
polyacrylamide gels (Fig. 5).  These analyses on individual colonies enable the detection 
of relatively small amounts of expansions and deletions which were not detected (see 
above) by the population studies by Southern blots.  The instability observed (Fig. 4, 
right side) is the composite instability of the (CCTG•CAGG)n repeats in the eukaryotic 
and prokaryotic systems.  In order to obtain the percentage of instability (expansions and 
deletions) in the mammalian system alone, the percentage of instability obtained from 
the prokaryotic cells was subtracted as the background (left side of Fig. 4).  Thus, the 
percentages of both expansions and deletions as depicted in the bar graphs in Fig. 6 
represent the net genetic instability of the (CCTG•CAGG)n tracts in the eukaryotic 
system.   
 Analyses of the digestion products from individual colonies by restriction 
digestion and polyacrylamide gels revealed four different types of products (Fig. 5): the 
unchanged starting length tetranucleotide repeats, expansions, deletions, and 
“rearrangements” which showed an alternate digestion pattern from that observed for 
full length, expansions and deletions.  In some cases, the rearrangements showed a 
digestion pattern in which the vector backbone was altered such that an expected 
fragment was missing (e.g. Fig. 5B, lane 5).  Previous studies (295-297) have shown 
these products to result from illegitimate recombination in vectors carrying the SV40 
origin of replication.  To confirm that the rearrangements arose from an inherent
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FIG. 5.  Genetic instability of the (CCTG•CAGG)n repeats.  The episomal DNA obtained from COS-7 
cells cultured for 2 weeks was digested to excise the tetranucleotide repeats and the products were 
analyzed on 5.5% polyacrylamide gels.  A-C, representative gels showing the various products of genetic 
instability of the (CCTG•CAGG)n repeats (A. pRW5110 B. pRW5112 C. pRW5114) cloned proximal to 
the SV40 origin of replication (SmaI site).  The repeats were excised using an EcoRI digestion.  D-F, 
representative gels showing the products of genetic instability of the tetranucleotide repeats (D. pRW5116 
E. pRW5118 F. pRW5120) cloned distal to the SV40 origin of replication (MfeI site).  The inserts were 
excised using an AflIII/BglII digest.  Lane M, 1 Kbp ladder, lane C, (CCTG•CAGG)n repeats excised 
from the parental plasmids used as controls.  The numbers above each gel indicate the various clones used.  
The arrowhead on the left side of each gel indicates the size of the full-length progenitor fragment whereas 
the brackets above and below the arrowheads indicate the expansions and deletions, respectively.  The 
clones that contained ‘rearrangements’ (see Results) are designated by arrows above each of the gels.  The 
arrowheads on the right side of each gel indicate the two fragments that result from the digestion of the 
vector and the faint bands between these two fragments result from an incomplete digestion, as seen in 
panels B, E and F. 
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property of the vector rather than a result of the presence of the (CCTG•CAGG)n inserts, 
the pcDNA3.1 vector (lacking the (CCTG•CAGG)n repeats) was transfected into COS-7 
cells.  The cells were cultured for 2 weeks and the episomal DNA isolated, DpnI cleaved 
and transformed into E. coli HB101.  The DNA from individual colonies was analyzed 
on a 1% agarose gel.  The number of rearrangements observed were similar to those 
obtained for the plasmids carrying the (CCTG•CAGG)n repeats.  Furthermore, no 
rearrangements were observed on analyzing individual colonies obtained from 
transforming the parental plasmids into E. coli HB101.  Likewise, rearrangements were 
not observed previously in other prior instability studies with triplet repeat inserts in E. 
coli HB101 (38,81,128-131,134,298,299).  This confirms that the rearrangements were 
due to an intrinsic property of the pcDNA3.1 shuttle vector that carries the SV40 origin 
of replication.   
Length-dependent Instability of the (CCTG•CAGG)n Tetranucleotide Repeats – 
For CTG•CAG, CGG•CCG, and GAA•TTC trinucleotide repeats, the number of repeat 
units plays an important role in genetic instability (38,81,129,130,165,300).  In order to 
evaluate the effect of the length of the (CCTG•CAGG)n tetranucleotide repeats (where n 
= 30, 114 or 200) on the genetic instability, three different lengths of the repeats were 
studied.  The percentage of expansions and deletions found for each of the 
(CCTG•CAGG)n repeats in COS-7 cells for a 2 week period is indicated in Fig. 6.  In 
general, the longer the length of the CCTG•CAGG tract, the greater the observed 
instability.  The (CCTG•CAGG)30 repeats were extremely stable (lack of any genetic 
instability) when the plasmids harboring these repeats were cultured in COS-7 cells for 
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FIG. 6.  Relative amounts of expansions and deletions of (CCTG•CAGG)n repeats.  The episomal 
DNA was isolated from COS-7 cells, which were cultured for 2 weeks, and the lengths of the 
tetranucleotide repeats were determined as described (Experimental Procedures).  The percentages of 
expansions and deletions of the tetranucleotide repeats were calculated by subtracting the background 
percentages obtained in E. coli HB101.  The expansion and deletion percentages of plasmids carrying the 
(CCTG•CAGG)n tracts (where n = 114 and 200) proximal (SmaI site) and distal (MfeI site) to the SV40 
origin of replication are indicated as bars above and below the line marked zero, respectively.  The black 
bars indicate the percentage of expansions and deletions for inserts in orientation I whereas the grey bars 
indicate the percentage of expansions and deletions for inserts in orientation II.  All data are the average of 
duplicate experiments with the appropriate background subtracted for each experiment.   
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both 48 h and 2 weeks (Fig. 5A and D).  A statistically significant difference in the 
genetic instabilities was observed between pRW5114 [(CCTG•CAGG)200 – orientation 
II] and pRW5112 [(CCTG•CAGG)114 – orientation II] (p = 0.003). Also, similar 
statistically significant differences in the genetic instability of these repeats were 
observed on comparing the two pairs of plasmids pRW5121 and pRW5119 (p = 0.012) 
and pRW5120 and pRW5118 (p = 0.010).  However, in the case of the plasmids carrying 
(CCTG•CAGG)200 cloned in orientation I proximal (SmaI site) to the SV40 origin of 
replication, a statistically significant length-dependant effect was not observed.   
Furthermore, the increase in genetic instability with an increase in the length of 
the (CCTG•CAGG)n tract was observed for repeats cloned both proximal (SmaI site) and 
distal (MfeI site) to the SV40 origin of replication.  Thus, there is a positive correlation 
between the length of the (CCTG•CAGG)n tracts and their genetic instabilities.   
Effect of Orientation – Prior genetic instability studies on microsatellites revealed 
the inequality of leading versus lagging strand DNA replication (i.e. the direction of 
replication) with respect to the types and amount of products (38,128,130,132,133,135-
137).  To determine if a similar orientation effect was observed for the tetranucleotide 
repeats, (CCTG•CAGG)n repeats were cloned in both orientations with respect to the bi-
directional SV40 origin of replication (see Experimental Procedures).  The percentage of 
instability (both expansions and deletions) obtained from plasmids cultured in COS-7 
cells for 2 weeks (Fig. 6) showed that orientation II was more unstable than orientation I, 
especially when the inserts were cloned in the SmaI site.  This effect was most 
pronounced for plasmids carrying the longest repeats.  Thus, a statistically significant 
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difference in instability was observed when comparing pRW5115 and pRW5114 (p = 
<0.001).  In experiments where the plasmids were cultured in COS-7 cells for 48 h, a 
similar effect was observed (data not shown) for (CCTG•CAGG)200.  Thus, once the 
tetranucleotide repeats reached a threshold of about 200 repeats, an orientation effect, 
where orientation II was significantly more unstable than orientation I, was observed.  
This was true of repeats cloned proximal (SmaI site) to the SV40 origin of replication.  
Alternatively, for repeats cloned distal (MfeI site) to the SV40 origin, the differences 
were not statistically significant, (Fig. 6), even for 48 h cultures (data not shown).   
 Furthermore, on analyzing the types of genetic instabilities i.e. expansions and 
deletions, it was observed that expansions in most cases predominated in orientation II 
compared to orientation I (Fig. 6); this behavior was especially pronounced for 
(CCTG•CAGG)200 when cloned into the SmaI site.  A 1.5 to at least 35 fold increase in 
expansions in orientation II compared to orientation I was observed which was 
dependant on the length of the (CCTG•CAGG)n repeats.  Analyses of the instability 
products from plasmids cultured in COS-7 cells for 48 h also showed a similar trend 
where expansions predominated in orientation II, especially in the case of the repeats 
cloned proximal (SmaI site) to the SV40 origin of replication (data not shown).  
Deletions were present in both orientations.  The percentage of deletions did in most 
cases increase as a function of length; however, an orientation effect was not observed. 
 Hence, the genetic instability was greater in the case of the repeats cloned in 
orientation II than in I and when the repeats were cloned proximal (SmaI site) rather than 
distal (MfeI site) to the SV40 origin.  Furthermore, as the length of the repeats increased, 
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the orientation effect was more pronounced.  Expansions predominated in orientation II 
compared to I, especially at the SmaI site.   
Magnitude of Expansions and Deletions – The ranges of expansions and 
deletions of the (CCTG•CAGG)n repeats cloned proximal (SmaI site) and distal (MfeI 
site) to the SV40 origin of replication is shown in Table I.  For the (CCTG•CAGG)n 
repeats cloned proximal (SmaI site) to the SV40 origin of replication (Table IA), the 
largest expansion product obtained from (CCTG•CAGG)114 (pRW5112) was a 
(CCTG•CAGG)210, showing a 1.84 fold increase in the number of repeats.  pRW5114 
expanded from 200 repeats to a maximum of 300 repeats, indicating a 1.5 fold increase 
in length.  Both of these expansions were obtained for the repeats cloned in orientation II 
(Table IA).  The deletions obtained for the (CCTG•CAGG)n repeats cloned proximal to 
the SV40 origin of replication ranged from a complete loss of the repeats to a reduction 
of 2 or 3 repeats (Table I).  Plasmids harboring the shortest repeats (n = 30) cloned into 
either of the sites were completely stable in all experiments.   
 The largest percent expansion obtained for the (CCTG•CAGG)n repeats cloned 
distal (MfeI site) to the SV40 origin (Table IB) was 56 repeats or 1.5 fold for pRW5119.  
The largest increase for (CCTG•CAGG)200 was 14 repeats.  The deletions ranged from a 
complete loss of repeats to a loss of only 2 or 3 repeats similar to those observed for 
repeats cloned proximal to the SV40 origin (Table IA).  Approximately 20 clones 
containing expansions were chosen at random and the inserts sequenced; all inserts 
contained the CCTG•CAGG repeat tracts within the limits of our detection.   
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TABLE I 
Expansions and deletions of (CCTG•CAGG)n repeats 
The episomal DNA was isolated from COS-7 cells cultured for 2 weeks and the sizes of the inserts were 
analyzed by restriction digestion and polyacrylamide gel electrophoresis (Experimental Procedures).  The 
ranges of expansions and deletions of the (CCTG•CAGG)n repeats are shown; in general, the distribution 
of product sizes within these ranges was random.  The bracketed values indicate the average of the 
observed values.  pRW5110 and pRW5116 were extremely stable after 2 weeks; hence, the data for these 
DNAs were derived from 48 h culture studies.   
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 The plasmids cultured in COS-7 cells for a period of 48 h (data not shown) 
showed expansions ranging between 118 to 144 repeats for (CCTG•CAGG)114 and 
between 202 to 370 repeats (up to1.85 fold)  for (CCTG•CAGG)200.  The deletions were 
also within a similar range as observed for the plasmids cultured for 2 weeks.  This range 
of expansions and deletions was similar for repeats cloned both proximal (SmaI site) and 
distal (MfeI site) to the SV40 origin.   
 In summary, a range of expansions and deletions were found.  The larger 
expanded products were found for the repeats cloned in orientation II compared to I.  
Furthermore, the magnitude of expansions was much larger for repeats cloned proximal 
to the origin than for repeats cloned distal.   
Oligonucleotide Model Studies: Enzymatic Probing – Two oligonucleotides, 
d(CAGG)26 and d(CCTG)26, were chemically synthesized to study their structural 
properties as related to the behavior of unpaired regions of the CCTG•CAGG repeats 
during replication and related processes that unwind the duplex.  d(CAGG)26 and 
d(CCTG)26 were purified and labeled (Experimental Procedures).  The labeled oligomers 
were then probed with conformation-sensitive enzymatic agents (S1 nuclease, P1 
nuclease and mung bean nuclease) (110,140,154,278,289-292,301).  All three enzymes 
have been used widely to evaluate ordered and H-bonded pseudo-duplex DNA regions 
within DNA tracts which are otherwise disordered, random-coil structures 
(109,110,278,290,301).   
 S1 nuclease from Aspergillus oryzae, a zinc requiring enzyme with an acidic pH 
optimum, cleaves single stranded and partially unpaired DNA and is not base-specific 
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(289,290,302).  On probing d(CAGG)26 with S1 nuclease (Fig. 7), the greatest reactivity 
was observed between the cytosine and adenine residues of the 14th CAGG repeat, 
followed by weaker cleavage between the adenine and guanine of the 14th CAGG repeat, 
as well as cleavage between the first and second guanine residues of the same repeat.  
Thus, these residues are more accessible to the enzymatic probe and may form a terminal 
loop of a hairpin structure.  The stem of the hairpin probed with S1 nuclease showed 
cleavage of the phosphodiester bonds between residues CpA, ApG and GpG (Fig. 7) but 
the intensity of cleavage in the proposed stem is weaker than that found in the putative 
loop (Fig. 7A).  Alternatively, on probing the labeled d(CCTG)26 (Fig. 8), an equal 
intensity of cleavage was observed between the CpT and TpG residues, suggesting the 
lack of formation of a stable secondary structure.   
 P1 nuclease from Penicillium citrium is similar in its behavior to S1 nuclease in 
preferentially cleaving single-stranded, non-helical DNA tracts or regions that are 
transiently unpaired (109,110,154,278,291,302).  However, P1 nuclease has a neutral pH 
optimum and lacks a requirement for zinc.  Probing the d(CAGG)26 substrate with P1 
nuclease further supported the evidence for formation of a terminal loop as demonstrated 
by the hypersensitivity of the substrate to this enzyme between the residues ranging from 
the adenine to the guanine residues of the 13th CAGG repeat and between the adenine 
and guanine of the 14th CAGG repeat.  Furthermore, cleavage was also observed 
between the cytosine and adenine residues of the 14th CAGG repeat (Fig. 7).  Cleavage 
occurred between ApG, GpG and CpA with the strongest cleavage between the ApG and 
GpG residues in the stem (as illustrated for repeat 10 but also found for all other repeats
 50
 
FIG. 7.  Analyses of the products of chemical and enzymatic probes on d(CAGG)26.  The preparation 
and characterization of the labeled synthetic oligonucleotide (CAGG)26 is described in Experimental 
Procedures.  A, analyses of the probing for oligonucleotide secondary structure on 10% polyacrylamide 
gels with 7.5M urea.  Data obtained from S1 nuclease (S1), P1 nuclease (P1), mung bean nuclease (MB) 
and diethylpyrocarbonate (DEPC) are shown.  The numbers to the right of each of the panels indicate the 
number of tetranucleotide repeats (as designated on the second G residue of the CAGG repeats).  
Increasing concentrations of enzymatic probes (4.3, 6.5 and 8.7U of S1 nuclease, 0.15, 0.2 and 0.25 µg/ml 
of P1 nuclease and 0.25, 0.5 and 1.0U of mung bean nuclease) are indicated by a triangle above each of 
the panels.  The triangle above the DEPC panel indicates an 8% DEPC solution used over two increasing 
time points of 30 min and 60 min. C - control (no probe added), G - size marker [Maxam-Gilbert 
sequencing with dimethyl sulfate (DMS)].  B, possible secondary structures formed by d(CAGG)26.  The 
reactivity of the oligonucleotide to the various probes has only been shown for the 10th CAGG repeat of 
the stem of the proposed hairpin loop structure for clarity; however, the same cleavage pattern was seen 
for all of the other CAGG repeats in the stem of the hairpin loop.  Furthermore, the cleavage of the 
phosphodiester bonds in the terminal loop of the hairpin has also been indicated.  The symbols 
corresponding to the various probes are shown to the right of the figure.  The length of the symbols 
corresponds to the cleavage intensity as quantitated using ImageQuant version 5.1.  The filled circles 
between the two DNA strands indicate Watson Crick pairing and the open circles denote non-Watson 
Crick pairing.   
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FIG. 8.  Analyses of the products of chemical and enzymatic probes on d(CCTG)26.  The results of the 
probing for oligonucleotide secondary structure in d(CCTG)26 using S1 nuclease (S1), P1 nuclease (P1), 
diethylpyrocarbonate (DEPC) and osmium tetraoxide (OsO4) are shown.  Analyses were performed in 
10% polyacrylamide gels with 7.5M urea.  Increasing concentrations of the enzymatic probes, (4.3, 6.5 
and 8.7U of S1 nuclease, 0.05, 0.1 and 0.15 µg/ml of P1 nuclease) are indicated as triangles above each 
panel.  The triangle above the panel for DEPC indicates two increasing time points of 30 and 60 min using 
an 8% DEPC solution.  The triangle above the panel for OsO4 indicates two increasing time points of 15 
and 30 min using 1mM OsO4 in the presence of 1mM 2,2'-bipyridine.  The numbers to the right denote the 
number of tetranucleotide repeats (as designated on the second G residue of the CCTG repeats).  C – 
control (no probe added), G – size marker [Maxam-Gilbert sequencing using DMS].   
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in the stem) (Fig. 7).  d(CCTG)26 showed a similar cleavage pattern to that observed with 
S1 nuclease when probed with P1 nuclease, where the phosphodiester bonds between the 
CpT and TpG residues were cleaved with an equal intensity (Fig. 8), again indicating 
that the d(CCTG)26 oligonucleotide did not form a stable secondary structure. 
 Mung bean nuclease is also highly sensitive to variations in DNA structure and 
converts single stranded or unpaired DNA to mono- or oligonucleotides with 5′-
phosphates (140,292,293,302).  The probing of d(CAGG)26 with mung bean nuclease 
showed predominant cleavage between the first and second guanines of the 13th CAGG 
repeat, the cytosine and adenine, as well as the first and second guanine residues of the 
14th CAGG repeat.  Less cleavage was observed between the adenine and guanine 
residues of the 14th CAGG repeat (Fig. 7).  These residues form the proposed terminal 
hairpin loop.  The bonds between the G’s of each of the CAGG repeats (Fig. 7) were 
more resistant to cleavage than for the bonds in the putative loops; thus, we propose that 
they exist in the stem.  Alternatively, the probing of d(CCTG)26 with mung bean showed 
cleavage of the bonds between GpC and CpC of each of the CCTG repeats (data not 
shown), thus indicating the lack of a stable secondary structure in agreement with the 
results from S1 and P1 nucleases.   
 Hence, the enzymatic probing studies revealed the preferential formation of a 
hairpin structure by d(CAGG)26 as opposed to d(CCTG)26.   
Chemical Probe Determinations – d(CAGG)26 and d(CCTG)26 were individually 
probed with OsO4 or DEPC or KMnO4.  OsO4 specifically reacts with thymines, and to a 
much lesser extent with cytosines, in single stranded oligonucleotides and single 
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stranded or distorted double stranded regions in DNA to yield mainly cis-thymine 
glycols (129,277,278,284-286).  OsO4/piperidine was used to probe d(CCTG)26 (Fig. 8).  
An equal intensity of cleavage was observed at each of the thymine residues of the 
CCTG repeats.  This indicates the equal accessibility of the pyrimidines and hence the 
oligonucleotide did not form any preferential secondary structure.  This probe was not 
used for the complementary oligomer since it lacked thymine residues.   
 DEPC reacts with the N7 positions of the purines, both adenines and guanines in 
single stranded DNA, to form the corresponding ring-opened dicarbethoxylated 
derivatives (115,129,275-277,279,280).  DEPC/piperidine was used to probe both 
d(CAGG)26 and d(CCTG)26.  Similar to the enzymatic probing, the most effective 
modification occurred at the adenine and the first guanine residues of the 13th CAGG 
repeat and at the adenine of the 14th CAGG repeat (Fig. 7) indicating the formation of a 
terminal loop of the putative hairpin structure.  The putative stem showed cleavage of 
the adenine residues to a greater extent than the guanine residues (Fig. 7) as previously 
stated.  In the case of d(CCTG)26, DEPC modified the G’s of each of the CCTG repeats 
and an equal intensity of cleavage was observed at all of the G’s (Fig. 8).   
 KMnO4 preferentially oxidizes unpaired or unstacked thymines (and to a much 
lesser extent cytosines) resulting in strand cleavage upon subsequent treatment with 
piperidine (110,278,281,282,288).  KMnO4 showed reactivity at all residues in the 
oligomer but a very prominent cleavage was observed at the cytosine residue in the 14th 
CAGG repeat of d(CAGG)26 (data not shown).  However, in the case of d(CCTG)26, 
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KMnO4 equally modified the thymine residues of each CCTG repeat (data not shown) 
indicating again the lack of any specific stable secondary structure.   
 Thus, the chemical modification studies further confirmed the results obtained 
from the enzymatic probing studies which indicate that d(CAGG)26, in contrast to 
d(CCTG)26, preferentially forms a stable hairpin structure.   
 
E.  Discussion 
DM2 is caused by the expansion of a CCTG•CAGG tetranucleotide repeat (236) 
from a normal range of ~ 26 to ~ 11,000 repeats.  Using an African green monkey 
kidney cell system, we demonstrate that replication-based slippage contributes to the 
genetic instability of these repeats.  The instability was dependent on the length of the 
repeats, their orientation, and their distance from the replication origin.  Furthermore, 
synthetic oligonucleotides representing the unpaired repeat regions during replication 
were analyzed with chemical and enzymatic probes revealing the preferential formation 
of hairpin structures by the CAGG oligomer, further supporting our structure-mediated 
replication-slippage model. 
 Prior genetic instability studies on CTG•CAG, CGG•CCG and GAA•TTC triplet 
repeats (5,38,81,128-130,134,139,165,174,256,257,298,299) have shown a length-
dependant effect on instability.  Similarly, the longest CCTG•CAGG repeat containing 
plasmids were the most unstable, especially after 2 weeks of culturing in COS-7 cells, 
generating both expansions and deletions when cloned proximal to the SV40 origin.  
However, when the repeats were cloned distal to the SV40 origin, deletions were 
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predominant.  Thus, for longer repeating sequences, an increase in the genetic instability 
was observed, as expected.   
To study the propensity of the CCTG•CAGG repeats to form non-B DNA 
structures, we analyzed the synthetic oligonucleotides d(CAGG)26 and d(CCTG)26 with 
chemical and enzymatic probes.  The modification patterns obtained for d(CAGG)26 
showed the formation of a folded back, hairpin structure.  Several different fold-back 
structures are possible (Fig. 9).  d(CAGG)26 can form hairpin structures with either 6, 5, 
4 or 3 unpaired residues in the terminal loop (Fig. 9A, B, C and D, respectively).  This 
would result in different Watson-Crick and non-Watson-Crick pairing schemes in the 
putative stems.  For the species shown in Fig. 9B and C, there would be no Watson-
Crick pairing making them less stable than the structures shown in Fig. 9A and D.  
However, the structure formed with 6 unpaired residues in the terminal loop (Fig. 9A) is 
more stable than that with 3 residues in the loop (Fig. 9D) due to the two non-Watson-
Crick A•G pairs that flank the Watson-Crick G•C pairs (Fig. 9A) compared to the A•A 
and G•G oppositions that flank the G•C pairs in structure 9D.  Although the stability of 
the mispairs is context dependent, an approximation of the pairing stabilities is G•C > 
A•T > G•G > G•T ≈ G•A > A•C+ > T•T ≈ A•A ≈ C•C+ > T•C ≥ A•C ≥ C•C (121-127).  
Previous studies have also indicated the greater stability of the loop of a hairpin with an 
even number of residues compared to an odd-numbered loop (303,304) as well as the 
favored closing of the loop with a 5′ pyrimidine and a 3′ purine pair (303,304).  Thus, 
our chemical and enzymatic probe results showed the formation of the structure (Fig. 
9A) which the above stated rationale predicts to be most stable.  Furthermore, DEPC 
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FIG. 9.  Theoretical hairpin structures formed by d(CAGG) and d(CCTG) oligonucleotides.  The 
various folded-back structures that can be formed by the d(CAGG) and d(CCTG) oligomers are shown in 
this figure.  Hairpin structures with either 6,5,4 or 3 residues in the terminal loop formed by slippage and 
misalignment of 0, 1, 2 or 3 nucleotides are shown for the d(CAGG) (A – D) and d(CCTG) (E – H) 
oligonucleotides.  The filled circles between the two DNA strands indicate Watson-Crick pairing and the 
open circles denote non-Watson-Crick pairing.  Although only ten CAGG and CCTG repeats are shown 
for simplicity, the same types of loops and pairing arrangements would apply to oligonucloetides of any 
length. 
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modified both the adenines and guanines at the N7 positions showing that this position is 
not involved in hydrogen bonding and that the G•A pairs are of the G(anti)•A(anti) or 
A(anti)•G(anti) types (123,126,305).   
Alternatively, d(CCTG)26 did not show the formation of any stable secondary 
structure that could be detected under our analytical conditions.  We believe this is due 
to the extremely unstable pairing schemes as shown in Fig. 9E – H.  The structures with 
4 and 3 unpaired residues in the terminal loops lack any Watson-Crick pairs (Fig. 9G 
and H, respectively) making them less stable than the structures with 6 and 5 residues in 
the loops (Fig. 9E and F, respectively).  Furthermore, the T•T mismatches as well as the 
C•T mispairs are extremely destabilizing (125,306) as stated earlier.  Thus, the possible 
base pairing arrangements reveal a greater probability that the CAGG strand forms a 
more stable structure than the CCTG strand.   
 A distinct orientation effect was observed for repeats cloned into the SmaI site 
where orientation II was significantly more unstable than orientation I.  For the triplet 
repeat sequences, instability was defined primarily as the loss of the full-length 
progenitor fragment.  Also, deletions were the predominant products of instability.  In 
case of the tetranucleotide repeats however, instability refers to both expansions and 
deletions.  Thus, upon initial consideration, our results appear to be similar to the results 
with the TRS, including CTG•CAG, CGG•CCG and GAA•TTC, in which orientation II 
was shown to be more unstable (5,38,128-137,165).  However, the CCTG sequences are 
genetically unstable in the orientation prone to expand (orientation II) (Fig. 10) as 
compared to the TRS that are unstable in the orientation prone to delete (orientation II).   
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Fig. 10 shows a mechanism for the orientation-dependant instability of the 
(CCTG•CAGG) sequences.  In 1995, Kang et al. (128) proposed the original model to 
explain the orientation-dependence of CTG•CAG sequences associated with DM1.  For 
this triplet repeat sequence, the CTG strand forms a more stable secondary structure than 
the CAG strand.  However, for the DM2 sequence, the CAGG strand (on either the 
nascent lagging strand or the lagging strand template) forms a more stable structure 
compared to the CCTG strand, generating expansions and deletions, respectively, as 
shown herein.  Thus, the tetranucleotide repeats cloned in orientation II are prone to 
expand whereas those cloned in orientation I are prone to delete (Fig. 10).  This is the 
first case of a “reversed” orientation behavior (5,38).  However, similar to the triplet 
repeats, the capability of one of the two DNA strands to form a quasistable folded 
structure, in our case the ability of the CAGG strand to adopt a hairpin structure, 
explains this “reversed” behavior.   
 The distance of the triplet repeats from the origin of replication plays an 
important role in the genetic instabilities of these repeats (R. R. Iyer and R. D. Wells, 
unpublished work) (128,131,137,307).  In our studies, the CCTG•CAGG repeats cloned 
proximal to the SV40 origin were more unstable than those cloned distal to the same 
origin.  Several hypotheses were described to explain this effect.  If an Okazaki initiation 
zone is a region of single-stranded template DNA, averaging 135 to 145 nucleotides (in 
eukaryotes) (137,308), where priming of the Okazaki fragments occurs, then depending 
on where the repeats fall within the Okazaki fragments (i.e. at the 5′ end or the 3′ end), 
their ability to form secondary structures would differ thereby influencing the amount of 
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FIG. 10.  Model for the orientation dependent instability of (CCTG•CAGG)n repeats in mammalian cells.  A, the presence of the CAGG repeats 
on the leading strand template and on the newly synthesized products of the lagging strand template (orientation II) can give rise to expansions since the 
CAGG repeats on the nascent strand can form folded-back secondary structures by strand slippage and thus generate expansions.  B, the presence of the 
CCTG repeats on the leading strand template and on the newly synthesized product of the lagging strand template (orientation I) preferentially gives rise 
to deletions since the CAGG repeats on the lagging strand template can form slipped structures which may be bypassed during synthesis (see 
Discussion). 
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instability observed (4,137,308).  Alternatively, we speculate that due to almost 
continuous initiation events occurring at the origin, the repeats cloned close to the origin 
would be rendered single-stranded for a longer period of time thereby giving the repeats 
a greater opportunity to fold-back and form a stable secondary structure.  Once 
replication has been initiated and the fork progresses away from the origin, the repeats 
lying distal to the origin do not have as great an opportunity to form these slipped 
structures on the leading strand.  However, due to the single-stranded nature of the 
Okazaki fragments on the lagging strand, both expansions and deletions can occur 
depending on the stability of the hairpin structures formed by these repeats.  The 
aberrant processing of the Okazaki fragments involving FEN-1 and DNA ligase has also 
been hypothesized to play an important role in generating genetic instabilities 
(165,168,169,171,220,309,310). 
Furthermore, polymerase switching (PolI/PolIII) has been implicated in E. coli to 
contribute to the genetic instability of triplet repeats (128,214).  Polymerase switching 
has also been proposed to occur during eukaryotic replication where following synthesis 
of the RNA-DNA primer by the polα-primase complex, replication is continued by polδ, 
both on the leading and lagging strands (294,311).  Thus, polymerase switching may 
further contribute to the observed instability of the tetranucleotide repeats. 
 In the present study, we have assayed for replication-based instability; however, 
transcription through the repeats could also have an influence on the levels of observed 
instability (80,81,224-227,312).  The (CCTG•CAGG)n repeats in our experiments, 
cloned into the SmaI site, fall within the promoter region of the neomycin resistance 
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gene that is transcribed.  Since this gene is transcribed to elicit the drug resistance, a 
further increase in the amount of instability could be obtained for repeats cloned 
proximal to the SV40 origin.  Also, the secondary structures formed by these repeats 
may cause both the transcription as well as the replication machinery to pause, as shown 
both in vitro and in vivo for triplet repeats (174,176,177,227).  This in turn could lead to 
activation of repair (4,38,91,133,136,141,165,205,213,214,218,266,300,313,314) and 
recombination (161,193,201,202,258) processes which, in the case of triplet repeats, are 
known to generate instability.   
 Thus, a complex interplay of replication, repair, recombination and transcription 
may effect the massive expansions observed in DM2.  In this study, we have specifically 
focused on replication and its role in generating the instabilities.  However, ongoing 
work implicates recombination as a powerful mechanism that contributes to the 
instabilities of the tetranucleotide repeats (R. Dere and R. D. Wells, manuscript in 
preparation).  These data provide the first insights into an understanding of the molecular 
mechanisms of the tetranucleotide instabilities.  Our ultimate goal is to understand the 
molecular processes causing these expansions in order to develop therapeutic strategies.   
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CHAPTER III 
THE EXPANSION PRONE RECOMBINATION HOTSPOT ACTIVITY OF THE 
CCTG•CAGG REPEATS IN ESCHERICHIA COLI  
 
A.  Overview 
Myotonic dystrophy type 2 (DM2) is caused by the extreme expansion of the 
repeating tetranucleotide CCTG•CAGG sequence from < 30 repeats in normal 
individuals to ~ 11,000 for the full mutation in certain patients.  This repeat is in intron 1 
of the zinc finger protein 9 gene on chromosome 3q21.  Since prior work demonstrated 
that CTG•CAG and GAA•TTC triplet repeats (responsible for DM1 and Friedreich’s 
ataxia, respectively) can expand by genetic recombination, we investigated the capacity 
of the DM2 tetranucleotide repeats to also expand during this process.  Both gene 
conversion and unequal crossing over are attractive mechanisms to effect these very 
large expansions.  (CCTG•CAGG)n (where n = 30, 75, 114 or 160) repeats showed high 
recombination frequencies (up to 27 fold higher than the non-repeating control) in an 
intramolecular plasmid system in E. coli.  Furthermore, a distinct orientation effect was 
observed where orientation II (CAGG on the leading strand template) was more prone to 
recombine.  Expansions of up to double the length of the tetranucleotide repeats were 
found.  Also, the repeating tetranucleotide sequence was more prone to expansions 
rather than deletions than observed for any of the three TRS.  Thus, the genetic 
instabilities of the CCTG•CAGG repeats are mediated by a recombination-repair 
mechanism.   
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B.  Introduction 
The massive expansion (up to 11,000 copies) of CCTG•CAGG repeats mapped 
to intron 1 of the zinc finger protein 9 (ZNF9) gene on chromosome 3q21 (236) are 
associated with myotonic dystrophy type 2 (DM2).  This is the first tetranucleotide 
repeat to be implicated in a hereditary neurological disease; almost twenty other 
neurological diseases are characterized by the expansions of triplet repeat sequences 
(TRS) (4-6,37,38,256).  Additionally, a pentanucleotide repeat ATTCT•AGAAT and a 
dodecamer CCCCGCCCCGCG•CGCGGGGCGGGG repeat were shown recently to be 
associated with spinocerebellar ataxia type 10 (SCA10) (235) and progressive 
myoclonus epilepsy of Unverricht-Lundborg type (EPM1) (228), respectively.  
However, the largest expansions of all repeating sequences involved in these 
neurological diseases were observed for DM2.  The longest normal allele sequenced was 
about 26 repeats, containing two interruptions, whereas the longest expansion in affected 
individuals was close to 11,000 repeats (236).   
 We have recently proposed a hairpin-structure mediated replication slippage 
model for the tetranucleotide genetic instabilities of DM2 (120).  However, the large 
expansions associated with this disease are not easily explained solely by this 
replication-slippage model.  Recombination is a powerful and plausible mechanism 
(38,161,193,201,202,258,315) for the generation of large expansions.  Chromosomal 
DNA is continuously challenged by a variety of damaging agents (such ionizing 
radiation and free radicals) and errors including those resulting from replication that can 
lead to double strand breaks (DSBs) (203,316-322).  These breaks are repaired via a 
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recombination-repair pathway, either by homologous recombination (HR), single-strand 
annealing (SSA) or non-homologous end joining (NHEJ) (321,323-330).  Although 
homologous recombination is believed to be the major pathway in prokaryotes (321,331-
335), there is evidence that SSA and NHEJ may also occur in these organisms 
(321,333,336-341).  Furthermore, a large number of DSBs / lesions within the DNA can 
cause the induction of the SOS response in bacteria (332,334,342-346) which could 
further increase the instability of the repeating tracts.   
 Herein, we show that the CCTG•CAGG tetranucleotide repeats associated with 
DM2 are recombination hotspots.  Analysis of the types of genetic instabilities in this 
intramolecular assay showed that expansions (lengths longer than a single tract) were the 
predominant products even with long lengths of the repeating tracts.  This is contrary to 
previous results with the TRS (CTG•CAG, and GAA•TTC) where deletions (lengths 
shorter than a single tract) were the preferential products of recombination.  The 
recombination frequencies were stimulated in the SOS+ strains as compared to the SOS¯ 
strain.  Thus, the large expansions observed in DM2 can be explained by a 
recombination-repair mechanism.   
 
C.  Experimental procedures 
Construction of the (CCTG•CAGG)n Containing Plasmids – The genetic assay 
used to study recombination was previously established to study the recombination 
behavior of CTG•CAG repeats (201).  Briefly, the (CCTG•CAGG)n inserts (where n = 
30, 75, 114 and 160) were cloned into the EcoRI/HindIII sites of pBR322.  This tract is 
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referred to as the X insert.  Another tract of the tetranucleotide repeats of the same length 
as the first tract was then cloned into the PvuII site of the pBR322 derivative carrying 
the X insert (referred to as the Y insert).  Furthermore, a GFPuv gene from the pGFPuv 
vector (B.D. Biosciences Clontech) was cloned at the EcoRV/EagI sites in the vector 
carrying two CCTG•CAGG tracts. 
 The (CCTG•CAGG)n repeats were excised with a EcoRV/EagI restriction 
digestion from the pCR2.1TOPO derivatives (kind gifts of Dr. L. P. W. Ranum, 
University of Minnesota) as done for our previous studies (120).  The insert containing 
fragments were blunt-end ligated into the EcoRI/HindIII site and PvuII site of pBR322 
as described above.  This was the cloning strategy for all the plasmids used in this study 
except for pRW5230.  In this case, problems were encountered during the cloning of the 
repeats and thus a slightly modified strategy was used.  The (CCTG•CAGG)160 insert 
was blunt-end ligated into the EcoRI/HindIII site of pBR322.  The clone containing the 
repeat tract in orientation I was chosen as the desired clone.  Simultaneously, the same 
insert was also cloned into the PvuII site of pBR322.  Again, the selected clone carried 
the repeat tract in orientation I.  The two clones thus generated were then digested with 
NdeI/BsgI and the two repeat containing fragments ligated to give rise to the plasmid 
carrying the two CCTG•CAGG tracts. The GFPuv gene was cloned into this plasmid as 
described above for all the remaining plasmids.   
 The plasmids carrying the (CCTG•CAGG)n repeats were characterized using 
restriction mapping and DNA sequencing to determine the length and orientation of the 
repeats.  The fragments obtained after restriction mapping were end-labeled with [α-32P] 
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dATP and 1 unit of the Klenow fragment of E. coli DNA polymerase I and analyzed on 
5.5% polyacrylamide gels in TAE buffer (40mM Tris acetate, 1mM EDTA, pH 8).  The 
sequencing reactions were performed using the Thermo Sequenase Radiolabeled 
Terminator Cycle Sequencing Kit (U. S. Biochemical Corp.) according to the 
manufacturer’s recommendations.  The products of the sequencing reactions were 
analyzed on 6% Long Ranger gels (FMC BioProducts) containing 7.5M urea in the 
glycerol tolerant gel buffer (1.78M Tris, 0.57M taurine and 0.01M EDTA) (U. S. 
Biochemical Corp.).  The (CCTG•CAGG)30 repeat tract is pure and uninterrupted as 
determined by DNA sequencing.  The (CCTG•CAGG)75 is also a pure repeat tract, 
however, in addition to the 75 tetranucleotide repeats there are 46 bp of human non-
repeating ZNF9 DNA flanking the repeats on one end and 140 bp on the other end.  The 
140 bp flanking the repeats included a (TG)16(TCTG)10•(CAGA)10(CA)16 tract 
immediately adjacent to the CCTG•CAGG repeats (236).  The (CCTG•CAGG)n tracts, 
where n = 114 or 160, carried an interruption 11 repeats into the tract to give the 
sequence (CCTG)11CCTT(CCTG)n where n = 102 and 148, respectively.  Thus, the 114 
and 160 tetranucleotide repeat tracts are also pure except for a TA pair in place of a GC 
pair in the twelfth repeat unit.  As stated in our previous replication studies with the 
CCTG•CAGG repeats (120), the long tracts of the tetranucleotide repeats were 
sequenced using primers located on either end of the repeating tract.  The estimation of 
the fragment length using restriction mapping had an error of ± 5 repeats for both 
(CCTG•CAGG)114 and (CCTG•CAGG)160. 
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 For all four repeat lengths, the CCTG•CAGG tracts were cloned in the direct 
repeat orientation with respect to each other.  Orientation I is defined as the orientation 
in which the CCTG repeats are on the template for leading strand DNA synthesis and 
when the CCTG repeats are on the lagging strand template it is referred to as orientation 
II.  A single plasmid (pRW5232) was created with two tracts of (CCTG•CAGG)160 in 
the inverted repeat orientation with respect to each other, i.e., the X tract was in 
orientation II whereas the Y tract was in orientation I.  Additionally, a plasmid carrying 
two tracts of a 354 bp non-repeating region of the DMPK gene (in the direct repeat 
orientation) was used as a control (201).  This plasmid was originally named 
pRW4871gfp (201); however, for our studies this plasmid was renamed pRW5233.  To 
evaluate the recombination properties of plasmids harboring two tetranucleotide tracts, 
the plasmids were maintained in E. coli HB101 which is Rec A⎯.  Previous studies 
(201,347-351) showed that intramolecular recombination occurs even in the absence of 
the RecA protein.  Therefore, the parental plasmids were separated and purified on 
agarose gels as described earlier (161,201). 
Bacterial Strains – The plasmids used in this study were maintained in E. coli 
HB101 (Invitrogen) (mcrB, mmr, hsdS20 (rB⎯, mB⎯), recA1, supE44, ara14, galK2, lacY1, 
proA2, rplS20 (SmR), xyl5, λ⎯, leuB6, mtl-1).  Two parental E. coli strains were used in 
our studies, AB1157 and KMBL1001.  AB1157 [thr-1, ara-14, leuB6, D(gpt-proA)62, 
lacY1,tsx-33, qsr[prime]-, glnV44(AS), galK2, l, arc-hisG4(Oc), rfbD1, mgl-51, 
rpsL31(smR), kdgK51, xylA5, mtl1, argE3(Oc), thi-1] was obtained from the E. coli 
Genetic Stock Center at Yale University (New Haven, CT).  KMBL1001 (no known 
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mutations) was obtained from Dr. Nora Goosen (Leiden Institute of Chemistry, The 
Netherlands).  Strains JJC510 (parental strain for the SOS response – SOS+) [GY4786; 
λ[p(sfiA::lacZ) CIind¯] ∆lac-pro, rpsL], JJC523 (constitutive induction of the SOS 
response – SOS+) [GY5425; recA441, sulA II, ∆lacI169, thi, leuB6, his4, argE3, ilvTS, 
galK2, rpsL37, lexA71::Tn5] and JJC123 (deficient for the SOS response – SOS¯) 
[GY6781; λ[sfiA::lacZ], ∆pro-lac, gal+, rpsL, mal::Tn9, LexAind1] were kind gifts from 
Dr. Benedicte Michel (Institut National de la Recherche Agronomique, France).  E. coli 
JH139 [dinD1::MudI1734 kanR lac] contains a dinD1::LacZ fusion which activates the 
β-galactosidase gene when the SOS response is induced and was a kind gift from Dr. 
Joseph Heitman (Duke University Durham, North Carolina).   
 Analyses of the Products of Recombination – The (CCTG•CAGG)n containing 
plasmids were transformed into the E. coli strains and the transformation mixtures were 
plated on LB plates containing ampicillin (100 µg/ml) as in our previous studies (201).  
Approximately 40 white colonies were picked at random from every plasmid 
transformed into every strain used. Liquid cultures were obtained from each of the 
individual colonies and DNA was isolated using alkaline lysis (Promega, Wizard Plus 
Miniprep DNA Purification System) and the supercoiled DNA was analyzed on 1% 
agarose gels in TAE buffer.  The products of recombination were then cleaved with 
AatII and NdeI and the fragments labeled using [α-32P] dATP and 1 unit of the Klenow 
fragment of E. coli DNA polymerase I.  The fragments were then analyzed on 5.5% 
polyacrylamide gels.  The 1 Kbp DNA ladder size standard (Invitrogen) was used as the 
size marker.  The lengths of each insert excised from individual colonies were 
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determined using FluorChem version 3.04 (Alpha Innotech Corp.).  Furthermore, ~ 100 
recombinants were sequenced using primers from both ends of the CCTG•CAGG 
tetranucleotide repeats to verify the lengths of the repeat tracts deduced from the 
restriction studies.  As stated previously, lengths of about 70 repeats were sequenced 
from both ends to enable the precise determination of the lengths; however, the longer 
repeat lengths which were determined by gel electrophoresis measurements gave an 
error of ± 5 repeats.   
 Assay to Evaluate the Induction of the SOS Response – In order to evaluate the 
role of the SOS repair in our studies, we tested the induction of this repair pathway using 
a β-galactosidase activity assay (352).  The plasmids harboring (CCTG•CAGG)160 in 
both orientations were transformed into E. coli JH139 and grown in K-media overnight 
at 37˚C.  The JH139 strain contains a dinD1::LacZ fusion that activates the β-
galactosidase gene on induction of the SOS response.  The overnight culture was diluted 
(1/100) the next day in fresh media and the cells were grown to mid-log phase.  The 
cultures were then chilled on ice to stop growth.  2 mL of the culture was then 
centrifuged at 4˚C and the cell pellet resuspended in an equal volume of chilled Z-buffer.  
The OD600 of these cells was measured.  0.5 mL of the culture was then added to the 
same volume of Z-buffer and the cells permeabilized by addition of 100 µl of chloroform 
and 50 µl of 0.1% SDS (sodium dodecyl sulfate) followed by vortexing for 10 s.  The 
reaction was started by addition of 200 µl of ONPG (o-nitrophenyl-β-D-galactosidase, 4 
mg/ml).  The time of addition of the ONPG was recorded and the cells were then 
incubated at room temperature until the yellow color was produced.  The reaction was 
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stopped by addition of 500 µl of 1M Na2CO3.  The time of addition was again noted and 
the OD420 and OD550 measured for each sample.  The Miller units of activity were 
calculated using the formula; 1000 x [(OD420 – 1.75 x OD550)] / (T x V x OD600) where T 
is the time of the reaction in minutes and V is the volume of culture used in the assay in 
mLs.  The pGEM vector (Promega) was used as the negative control lacking any 
repeating tracts.   
 
D.  Results 
Strategy of Study – The intramolecular genetic assay used for our studies was 
previously established (161,201).  The (CCTG•CAGG)n tetranucleotide repeats (where n 
= 30, 75, 114 and 160) were used to construct the family of molecules shown in Fig. 11.  
All of these plasmids contain a GFP gene cloned between two tracts of the repeat 
sequence in the direct repeat orientation with respect to each other.  The presence of the 
GFP gene results in green colonies.  Recombination between the two repeating tracts 
leads to the loss of the GFP gene which gives rise to white colonies thus, providing a 
useful green-white screen for measuring recombination events.  The frequency of 
recombination was calculated as a ratio of the number of white colonies to the total 
number of colonies (Fig. 11A) (201).  Additional controls, including plasmid copy 
number determination, growth advantage control and plasmid establishment control 
were previously conducted and shown to not influence the frequency of intramolecular 
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FIG. 11.  Plasmids used in the study.  A, the (CCTG•CAGG)n containing plasmids were transformed into 
the E. coli strains used in our study and plated to obtain green colonies (black spots) and white colonies 
(white spots).  The frequency of recombination was calculated as a fraction of the number of white 
colonies over the total number of colonies.  B, the (CCTG•CAGG)n repeats (where n = 30, 75, 114, and 
160) were cloned in the direct repeat orientation into the EcoRI/HindIII site of the pBR322 vector (X tract) 
and into the PvuII site of the same derivative (Y tract) (see Experimental Procedures).  The repeats were 
cloned in both orientations I and II.  Orientations I and II are defined in the Experimental Procedures.  
Additionally, two control plasmids, one with (CCTG•CAGG)160 cloned as indirect repeats (pRW5232) and 
the other carrying two tracts of the 375 bp DMPK DNA cloned as direct repeats (pRW5233), were also 
prepared for our studies.  All plasmids contain the GFP gene.   
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recombination (161,201).  A control plasmid (pRW5233) carrying two 354 bp of random 
DMPK DNA in the direct repeat orientation was also used in these studies.  All 
statistical analyses were perfomed using SigmaStat version 2.03.  Statistical differences 
(p-values) were calculated using the z-test.   
CCTG•CAGG Repeats Are Recombination Hotspots – Two parental E. coli 
strains, AB1157 and KMBL1001, were used to study the recombination behavior of the 
tetranucleotide repeats.  The plasmids carrying the CCTG•CAGG repeats gave high 
frequencies of recombination, in comparison to the controls in both E. coli strains (Table 
II).  In all cases, the frequencies obtained for plasmids transformed into E. coli 
KMBL1001 were lower than those obtained for plasmids transformed into E. coli 
AB1157.  However, the general trends remained the same in both strains indicating that 
the genetic backgrounds of the host strains could potentially influence the frequency of 
recombination.  The effect of different genetic backgrounds on the genetic instabilities of 
triplet repeat sequences (TRS) has been reported (353).  A control plasmid (pRW5233) 
carrying two tracts of a 354 bp random DMPK DNA sequence was used in our studies, 
which gave frequencies of 0.5% and 0.2%, respectively, when transformed into E. coli 
AB1157 and KMBL1001 (Table II). Also, an additional control (pRW5232) carrying 
160 CCTG•CAGG repeats in the inverted repeat orientation with respect to each other, 
when transformed into E. coli AB1157 resulted in no white colonies, as previously 
reported (201).  Other workers (347,354,355) also demonstrated the necessity of repeats 
in the direct orientation for successful recombination. 
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Two major factors influenced the frequencies of recombination, the length of the 
repeats and their orientation with respect to the unidirectional ColE1 origin of 
replication.  A distinct length effect was observed in both strains, where the frequency of 
recombination increased in a linear fashion with an increase in the length of the 
repeating CCTG•CAGG sequence (Table II).  Thus, (CCTG•CAGG)30 showed a 2 fold 
increase in frequency when compared to the control plasmid (pRW5233) that further 
increased in a linear fashion to a 27 fold increase for the (CCTG•CAGG)160 containing 
plasmid in E. coli AB1157.  This relationship has been reported previously for the 
CTG•CAG sequence and for the GAA•TTC sequence (in the absence of the sticky DNA 
forming propensity of the GAA•TTC sequence) (161,201).  A similar trend was also 
observed for the plasmids transformed into E. coli KMBL1001 (Table II).  Although the 
frequencies were slightly lower in KMBL1001, the fold difference between the 
frequencies for the various lengths of the CCTG•CAGG repeats remained almost the 
same for both parental strains.  For example, there is a 13.7 fold increase in the 
frequency of recombination for pRW5231 [(CCTG•CAGG)160, orientation II] when 
compared to pRW5225 [(CCTG•CAGG)30, orientation II] in E. coli AB1157 which is 
similar to the 14.6 fold increase seen between the same plasmids in E. coli KMBL1001.   
Furthermore, an orientation effect was also observed where the frequency of 
recombination was higher for plasmids carrying the CCTG•CAGG tetranucleotide 
repeats in orientation II (Table II).  In this orientation, the CCTG repeats lie on the 
template for lagging strand synthesis.  In E. coli AB1157, a significant difference was 
observed between the orientations for plasmids carrying repeat lengths of 75, 114 and
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TABLE II 
Frequency of recombination in parental strains E. coli AB1157 and KMBL1001 
 
The CCTG•CAGG tetranucleotide repeat containing plasmids were transformed into the parental strains, 
E. coli AB1157 and KMBL1001.  The frequency of recombination was obtained by dividing the number 
of white colonies by the total number of colonies.  The frequencies for each of the plasmids used in our 
studies in both orientations are shown.  The frequency of recombination for pRW5232, carrying the two 
tracts of CCTG•CAGG as inverted repeats, was obtained only for E. coli AB1157 and not for KMBL1001 
(as indicated by the dash).   
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160 (p = <0.001).  However, there was no statistically significant difference (p = 0.221) 
for (CCTG•CAGG)30 repeat containing plasmids.  In the case of E. coli KMBL1001, a 
difference between the orientations was observed in all cases (p = <0.001) including the 
30-mer.  All the plasmids carrying the repeats cloned in orientation II showed a 1.2 – 1.6 
fold higher frequency of recombination in both E. coli strains. 
Thus, both the length and orientation of the CCTG•CAGG repeats influenced the 
frequency of recombination; longer repeats cloned in orientation II show a higher 
frequency compared to shorter lengths in orientation I.   
Recombinants Are Prone to Expand – The recombinants (white colonies) from 
each of the plasmids transformed into the parental E. coli strains were analyzed using 
agarose gel electrophoresis.  The supercoiled DNA isolated from individual white 
colonies migrated faster than the parental plasmids at a distance representing 
approximately 2 kbp on the gel (data not shown), indicating that smaller plasmids were 
formed due to recombination between the two homologous CCTG•CAGG tracts and the 
loss of the intervening vector sequence including the GFP gene.  Furthermore, the DNA 
was subjected to restriction mapping and polyacrylamide gel electrophoresis to estimate 
the length of the single recombined tetranucleotide tract in the recombinants.  The 
expanded clones carry CCTG•CAGG lengths longer than a single tract of the parental 
plasmid whereas the deleted clones have fewer than the number of repeats in a single 
tract of the starting parental plasmids.  The expanded clones never carried more repeats 
than the sum of the two tracts (see below). 
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The plasmids transformed into both E. coli strains showed a high propensity for 
expansions, especially when transformed into E. coli KMBL1001 (Fig. 12).  In the case 
of (CCTG•CAGG)30 (pRW5224), 80% of the recombinants in E. coli AB1157 had 
expanded tetranucleotide repeats.  On increasing the length of the repeating tract, the 
percentage of expanded clones still remained high with (CCTG•CAGG)160 (pRW5231) 
showing 59% of the recombinants with expansions.  There was no statistically 
significant difference between the two orientations for the percentages of expanded and 
deleted clones.  This was true for all plasmids except pRW5228 [(CCTG•CAGG)114, 
orientation I] and pRW5229 [(CCTG•CAGG)114, orientation II] transformed into E. coli 
AB1157 where a significant difference was observed; orientation I showed a higher 
percentage of deleted clones and orientation II showed a higher percentage of expanded 
clones (Fig. 12).  Although this fits well with the model proposed in our previous studies 
(120) where the CCTG•CAGG repeats in orientation I are prone to delete and those in 
orientation II are prone to expand, the reason for this difference is uncertain.  In E. coli 
KMBL1001, no difference was observed in the percentage of expanded and deleted 
clones between the two orientations, except for (CCTG•CAGG)30 and (CCTG•CAGG)75 
where the percentage of deleted clones was significantly higher in orientation I and II, 
respectively (Fig. 12).   
The high percentage of expanded clones observed in our studies is unique to the 
CCTG•CAGG tetranucleotide repeats.  Previous studies with TRS including CTG•CAG 
and GAA•TTC showed a significant decrease in the percentage of expanded clones with 
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FIG. 12.  Analyses of the lengths of the recombination products.  The (CCTG•CAGG)n inserts (where n 
= 30, 75, 114 and 160) were excised from the recombinants (white colonies) and analyzed for their lengths 
using restriction mapping (see Experimental Procedures).  The percentages of expanded and deleted clones 
are shown for each of the tetranucleotide lengths.  The bars above zero percentage indicate expanded 
clones whereas the bars below zero show the deleted clones.  The crosshatched bars indicate the 
percentage of expansions and deletions for inserts cloned in orientation I whereas the filled bars indicate 
the percentage of mutations for inserts in orientation II.  The data for each bar was collected from the 
analyses of 40 colonies from duplicate experiments.   
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an increase in the number of repeats (161,201).  Conversely, a high proportion of deleted 
clones were associated with an increase in the length of the repeating tract.  Herein, we 
found that even with long lengths of the (CCTG•CAGG)n tract, a large number of 
recombinants are expanded.  As shown in Fig. 13 the percentage of expanded clones in 
the case of (CCTG•CAGG)160 (640 bp) is as high as 50%.  In case of the triplet repeat 
CTG•CAG, the percentage of expanded clones is highest (31%) for the plasmid carrying 
67 CTG•CAG repeats.  In terms of bp, 294 bp (98 repeats) of CTG•CAG repeats show 
20% expanded clones whereas, 300 bp (75 repeats) of the CCTG•CAGG repeats show 
39%, almost twice the percentage of expanded clones.  Increasing the number of bp to 
495 for the triplet repeat (165-mer) decreases the percentage of expanded recombinants 
to 10% whereas for a corresponding 456 bp of the tetranucleotide repeat sequence (114-
mer), the percentage is 60 (Fig. 13).  Similarly, 495 bp of CTG•CAG shows 85% of 
deleted clones whereas a similar length of 456 bp of the CCTG•CAGG sequence shows 
36%, almost half the number of deleted clones (Fig. 13).  
Thus, the CCTG•CAGG repeats show a high frequency of recombination to yield 
a large percentage of expanded clones, emphasizing the unique ability of this repeat 
sequence to expand.   
Magnitude of Expanded and Deleted Clones – The length ranges of expanded 
and deleted products for the plasmids (Fig. 11B) transformed into the parental E. coli 
strains is shown in Table III.  The largest increase in the number of repeats was the sum 
of the two repeat tracts seen for pRW5229 [(CCTG•CAGG)114, orientation II] and 
pRW5230 [(CCTG•CAGG)160, orientation I] in the case of E. coli AB1157.  However,
  
81
 
 
 
 
 
FIG. 13.  A comparative analysis of the expansions associated with CCTG•CAGG repeats as 
compared to CTG•CAG repeats.  The recombinants obtained from experiments with the CTG•CAG 
containing plasmids (201) and the CCTG•CAGG plasmids were analyzed on polyacrylamide gels.  The 
data obtained from both orientations I and II was pooled since there was no significant difference between 
the two orientations.  The filled bars indicate the percentage of expanded clones, whereas the white bars 
indicate the percentage of deleted clones (Z-axis).  The number of bp of repeats in both the trinucleotide 
and tetranucleotide containing plasmids is indicated on the Y-axis.  The two rows show the 
(CCTG•CAGG)n repeats (where n = 30, 75, 114 and 160 corresponding to 120, 300, 456 and 640 bp) and 
the (CTG•CAG)n repeats (where n = 17, 67, 98 and 165 corresponding to 51, 201, 294 and 495 bp) (X-
axis).   
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most of the other plasmids also showed between a 1.5 – 1.9 fold increase in the number 
of repeats when compared to the starting length (the length of a single tract) (Table III).  
E. coli KMBL1001 showed expanded recombinants carrying a tetranucleotide repeat 
tract up to twice the length of the tract in the parental plasmids (pRW5225, pRW5226, 
pRW5228 and pRW5230).  The largest deletion was the complete loss of the 
CCTG•CAGG repeats observed for pRW5224 [(CCTG•CAGG)30, orientation I] in E. 
coli AB1157.  The smallest deletion was the loss of only 2 – 3 repeats.  pRW5225 
[(CCTG•CAGG)30, orientation II] did not yield any deleted clones when transformed 
into E. coli KMBL1001 (Table III). 
Almost 40 recombinants from both E. coli strains were randomly selected and 
sequenced to confirm the lengths and determine the sequence of the repeating tract (data 
not shown).  The sequence analysis showed the presence of one CCTG•CAGG tract 
flanked on either side by the vector sequence as seen in the case of our previous studies 
(161,201).  Lengths of approximately 70 – 80 repeats were sequenced to precisely 
estimate the number of repeats, however longer lengths of the repeating tract were 
sequenced using primers from both ends of the repeating tract.  The lengths of these 
longer tracts were estimated using electrophoretic techniques as stated in the above 
section, giving an error of ± 5 repeats.   
Thus, a range of expansions and deletions were found in both orientations for 
plasmids carrying the CCTG•CAGG repeats.   
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TABLE III 
Magnitude of expanded and deleted products from the recombination of the (CCTG•CAGG)n repeats in 
the parental E. coli strains 
 
The plasmids were isolated from the recombinant (white) colonies and the lengths of the CCTG•CAGG 
inserts were analyzed by restriction digestion and polyacrylamide gel electrophoresis (see Experimental 
Procedures).  The ranges of the number of repeats for different plasmids in the expanded and deleted 
products are shown for each of the two E. coli parental strains, AB1157 and KMBL1001.  The estimated 
repeat lengths varied by ± 5 repeats for plasmids carrying 75, 114 and 160 repeats.  The inserts from the 
plasmids carrying 30 repeats were sequenced to obtain the precise length of the inserts in the 
recombinants.  The recombinants obtained from transformation of pRW5225 into KMBL1001 yielded no 
deletion products.  The numbers in brackets following the names of the plasmids are the numbers of the 
repeats in the parental plasmids.   
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Stimulation of Recombination Frequencies in Strains with an Active or Inducible 
SOS response – Previous studies have shown intramolecular recombination frequencies 
to be elevated by, but not dependent on, the presence of RecA (201,347-351).  The RecA 
protein plays a crucial role not only in homologous recombination (HR) but also in the 
SOS-repair pathway.  In this pathway, RecA in its active form cleaves the LexA 
repressor, thus regulating all the genes under the SOS regulon.  In order to determine the 
extent of involvement of the SOS-repair pathway in our intramolecular recombination 
assay, we used three SOS-mutant E. coli strains, JJC510 (parental for the SOS response), 
JJC523 (which constitutively expresses the SOS response) and JJC123 (SOS¯). 
The frequencies of recombination for plasmids transformed into the E. coli SOS 
mutant strains are shown in Fig. 14.  The repeat tract length and orientation influenced 
the recombination frequencies, similar to our results with E. coli AB1157 and 
KMBL1001.  Moreover, the frequencies obtained in the parental JJC510 strain were 
similar to those obtained with E. coli AB1157 (Table II).  Although high frequencies 
were observed for E. coli JJC510, the frequencies fell significantly in E. coli JJC123 
(non-inducible SOS response) (Fig. 14).  In orientation II, a statistically significant 
difference (p = < 0.001) in frequencies was obtained for plasmids carrying 114 and 160 
repeats in JJC123 (SOS¯) (2.9 and 4.7 %, respectively) when compared to the parental 
strain JJC510 (6.6 and 15 %, respectively).  Furthermore, all plasmids transformed into 
the strain in which the SOS-repair is constitutively expressed (JJC523) showed a higher 
frequency than those transformed into JJC123 (p = < 0.001) (Fig. 14).  Similar results 
were obtained for plasmids carrying the repeats in orientation I (data not shown), where 
  
85
 
 
 
 
 
 
FIG. 14.  Frequency of recombination in the SOS mutant strains.  The frequency of recombination as a 
percentage was plotted as a function of the length of the (CCTG•CAGG)n repeat containing plasmids.  The 
(CCTG•CAGG)n containing plasmids (where n = 30, 75, 114 and 160) were transformed into E. coli 
JJC510 (parental strain for SOS repair), JJC523 (SOS+) and JJC123 (SOS¯).  The frequency of 
recombination for plasmids carrying the CCTG•CAGG repeats cloned in orientation II (filled symbols) is 
shown.  The circles, squares and triangles represent plasmids transformed into the SOS mutant strains 
JJC510, JJC523 and JJC123, respectively.  The frequencies of recombination obtained from the control 
plasmid pRW5233 transformed into JJC510, JJC523 and JJC123 are 1.2, 0.4 and 0.1 percent, respectively.  
The standard deviations for the three experiments performed with each of the plasmids are indicated as 
error bars.   
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significant differences were observed between the strains harboring plasmids with all 
three (75, 114 and 160) repeat lengths.   
Thus, there is a significant decrease in the frequency of recombination for 
pRW5231 [(CCTG•CAGG)160, orientation II] in E. coli JJC123 compared to JJC510 (a 
3.2-fold decrease) and JJC523 (a 2.5-fold decrease). 
The SOS-repair Pathway is Not Induced by the CCTG•CAGG Repeats – To 
explain the high frequencies of recombination in the SOS+ strains, we determined the 
level of induction of the SOS response by the repeat containing plasmids.  E. coli JH139 
carries a dinD1::LacZ fusion protein that activates the β-galactosidase gene if the SOS 
response is, in fact, induced.  The plasmids harboring the longest CCTG•CAGG repeats 
were transformed into this strain and a β-galactosidase activity assay was performed to 
measure the amount of expression (Experimental Procedures).  A pGEM plasmid 
lacking the repeats was used as a negative control.  On measuring the levels of β-
galactosidase produced in the assay, we determined that there was no difference in the 
amounts obtained from the control and the experimental plasmids harboring the repeats 
(data not shown).  Furthermore, the amount of expressed protein was equivalent to the 
amounts obtained in the absence of induction.  Thus, the differences in the frequencies 
of recombination obtained in the SOS¯ strain, the parental (JJC510) and constitutively on 
(JJC523) strain may be due to differences in these isogenic strains (Discussion). 
Repeat Tracts in Recombinants from the SOS+ and SOS¯ Strains Are Similar in 
Length – Analyses of expanded and deleted clones obtained from plasmids in the SOS-
mutant strains revealed similar results to those seen in E. coli AB1157.  A large number 
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of expanded clones were observed in all three E. coli strains; JJC510 is the parental 
strain for the SOS response (SOS+), JJC523, constitutively induced SOS (SOS+), and 
JJC123 (SOS¯) (Fig. 15).  The largest percentage of expanded clones was 76%, observed 
for pRW5229 [(CCTG•CAGG)114, orientation II] in E. coli JJC510 (Fig. 15A).  
pRW5227 [(CCTG•CAGG)75, orientation II] carried 81% deleted clones in E. coli 
JJC523 (Fig. 15B).  On analyzing the lengths of the inserts (within the limits described 
above), a range of both expansions and deletions were obtained (Table IV).  Again, the 
ranges were similar to those found with E. coli AB1157 and KMBL1001 (Table III).  All 
the expanded clones showed a 1.5 – 2.0 fold increase in the length of the tract.  Thus, the 
percentages of expanded and deleted products remained the same in all three mutant 
strains although the frequencies of recombination were significantly different.   
 
E.  Discussion 
Myotonic dystrophy type 2 (DM2) is caused by a very large expansion of the 
CCTG•CAGG repeats (by an average of ~ 5000 repeats) in intron 1 of the zinc finger 
protein 9 (ZNF9) gene on chromosome 3q21 (236).  Our recent work has shown a 
hairpin-structure forming propensity of these tetranucleotide repeats to lead to the 
observed genetic instabilities due to replication slippage (120).  However, the massive 
expansions (up to ~ 11,000 repeats) associated with DM2 (236) are not easily explained 
solely by a slippage based mechanism.  Herein, we showed the CCTG•CAGG repeats to 
be recombination hotspots which are prone to expand; this tendency towards expansions
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FIG. 15.  Analyses of the lengths of the recombination products.  The (CCTG•CAGG)n inserts (where n 
= 30, 75, 114 and 160) were excised from the recombinants (white colonies) derived from the experiments 
described in Fig. 14 and were analyzed for their lengths using restriction mapping (see Experimental 
Procedures).  The percentages of expanded and deleted clones are shown for each of the tetranucleotide 
lengths.  The bars above zero percentage indicate expanded clones whereas the bars below zero show the 
deleted clones.  The crosshatched bars indicate the percentage of expansions and deletions for inserts 
cloned in orientation I whereas the filled bars indicate the percentage of expansions and deletions for 
inserts in orientation II.  The data for each bar was collected from the analyses of 40 colonies.  A, E. coli 
JJC510, B, E. coli JJC523, and C, E. coli JJC123.   
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TABLE IV 
Magnitude of expanded and deleted products from the recombination of the (CCTG•CAGG)n repeats in 
the SOS mutant strains 
 
The plasmids were isolated from the recombinant (white) colonies and the lengths of the CCTG•CAGG 
inserts were analyzed by restriction digestion and polyacrylamide gel electrophoresis (see Experimental 
Procedures).  The ranges of the number of repeats for different plasmids in the expanded and deleted 
products are shown for each of the three SOS mutant strains, JJC510 (parental), JJC523 (SOS +) and 
JJC123 (SOS¯).  The estimated repeat lengths varied by ± 5 repeats for plasmids carrying 75, 114 and 160 
repeats.  The inserts from the plasmids carrying 30 repeats were sequenced to precisely obtain the length 
of the inserts in the recombinants.  The numbers in brackets following the names of the plasmids are the 
numbers of the repeats in the parental plasmids.   
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in contrast to deletions is unique compared to all previous studies on CTG•CAG and 
GAA•TTC repeats (161,201).  Recombination is a plausible mechanism (193,258,315) 
to mediate expansions.  Furthermore, we evaluated the involvement of the SOS repair 
pathway in this recombination assay and found that although the recombination 
frequencies were significantly higher in the SOS+ strain compared to the SOS¯ strain, the 
SOS response itself was not induced.   
The intramolecular assay used for our studies was established previously to study 
the recombination behavior of the CTG•CAG (201) and GAA•TTC (161) repeats.  Using 
this assay we showed that the frequency of recombination of the CCTG•CAGG repeats 
increased with an increasing length of the repeats.  The frequency of recombination was 
27 fold higher for pRW5231 [(CCTG•CAGG)160, orientation II] than for the control 
containing two 354 bp DMPK DNA fragments (pRW5233).  Similar studies with the 
DM1 sequence showed only a 13 fold increase for the longest CTG•CAG tract (165-mer, 
orientation II) (201).  In terms of bp, the (CCTG•CAGG)114 is closest to (CTG•CAG)165 
and showed a 21 fold increase.  Thus, the CCTG•CAGG repeats are indeed 
recombination hotspots and recombined giving higher percentages of recombination 
frequencies than their DM1 counterparts (201).   
A distinct orientation effect was observed where orientation II showed higher 
frequencies of recombination as compared to orientation I.  Similar studies conducted 
with the CTG•CAG repeats also showed high frequencies in orientation II (201).  In the 
case of the TRS, this orientation effect was attributed to the ability of the CTG tracts to 
form a stable folded-back structure (as opposed to the complementary CAG strand) on 
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the lagging strand template, giving rise to deletions.  Our previous studies (120) on the 
DM2 sequence showed the repeats to be unstable in the orientation prone to expand 
(orientation II), due to the propensity of the CAGG strand (on the nascent lagging 
strand) to adopt a stable hairpin loop.  The complementary CCTG strand did not exhibit 
any structure-forming capability in our studies.  We believe that the differences between 
the stabilities of the hairpin-loops formed by each of these repeats may contribute to the 
observed differences in orientation.   
A model in which breaks occurring at the repeat tracts can lead to homologous 
recombination (HR) is proposed in Fig. 16A.  We hypothesize that initiation of 
replication from the origin leads to the opening of the DNA duplex within the 
CCTG•CAGG repeats (step A).  The tetranucleotide repeats in orientation II (where 
CAGG is on the newly synthesized lagging strand) have the opportunity to form hairpin-
loop structures on the lagging strand (step B).  The potential repair of these structures 
may generate double strand breaks (DSBs) within the CCTG•CAGG repeats of the Y 
tract.  DSBs in prokaryotes are mainly repaired by HR (step D) and the required 
homology is provided by the X tract in our studies.  The recombination between the two 
tracts can lead to either gene conversion or cross-over events 
(97,189,193,258,319,321,338) (Fig. 16A).  The gene conversion events (step E) would 
not be detected in our assay since the colonies are still green due to the presence of the 
GFP gene.  Alternatively, the recombination event between the two CCTG•CAGG tracts 
can lead to a cross-over (step F), which leads to a deletion of the intervening sequences 
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FIG. 16.  Model for the recombinational repair of the CCTG•CAGG repeats.  A, the replication 
process causes duplex unwinding that gives the CCTG•CAGG repeats the opportunity to form hairpin 
loops that could lead to replication pausing and eventually double strand breaks (DSBs).  These breaks 
could be processed by homologous recombination (HR) as shown to give rise to either gene conversion or 
crossover events depending on the resolution of the Holliday junctions.  The crossover that is observed in 
our system gives rise to a smaller plasmid that would carry the origin of replication (ori) and the ampicillin 
resistance gene (AmpR) along with the single recombined CCTG•CAGG tract. 
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FIG. 16. Continued. B, the replication process causes duplex unwinding that gives the CCTG•CAGG 
repeats the opportunity to form hairpin loops that could lead to replication pausing and eventually double 
strand breaks (DSBs).  DSBs could be repaired by single-strand annealing (SSA) if two breaks occur 
simultaneously in both repeat tracts as shown.   
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between direct repeats.  This would result in the formation of two products (Fig. 16A); 
one is a smaller recombined plasmid carrying a single recombined CCTG•CAGG tract 
along with the origin of replication and the resistance gene, and the other product is a 
fragment carrying the GFP gene and probably some CCTG•CAGG repeats depending on 
where the crossover occurred, which is inviable due to a lack of the origin and the drug 
resistance gene.  These are the products detected in our studies.   
Analyses of the recombinants revealed that a high proportion of the clones 
carried expansions (lengths longer than the length of a single tract in the original 
plasmid).  This is quite different from the results with the CTG•CAG and GAA•TTC 
repeats (161,201), where longer (up to 495 bp) repeats showed a decreased percentage of 
expanded clones compared to shorter repeats (up to 51 bp).  Herein, even the longest 
tetranucleotide repeat carrying 160 repeats (640 bp) still showed 50 % expanded clones. 
Moreover, a range of expanded clones was observed, including some clones which had 
expansions almost twice the size of the starting length, i.e. 320 repeats (1280 bp).   
We used the Mfold program (http://www.bioinfo.rpi.edu/applications/mfold) to 
determine the theoretical stabilities of the CTG, CAG, CCTG and CAGG hairpin loops.  
The CTG hairpin was found to be most stable with a ∆G value almost 3.5 times more 
negative than the ∆G value obtained for the CAGG repeats of similar length.  We 
propose that this lower stability of the structure formed by the CAGG repeats contributes 
to its expansion behavior.  The tetranucleotide sequence may fold-back into a hairpin-
loop but may collapse before the structure can be detected and repaired by the repair 
pathways.  However, the transient formation of these structures may still be sufficient to 
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result in expansions either during replication by causing impediments to the replication 
fork or due to a less efficient repair pathway.  This could lead to breaks which could then 
be repaired by recombination-repair.  In the case of the CTG•CAG repeats, the repair of 
the stable structure formed by the repeats could be more efficient leading to deletions.  
Additionally, this lack of stability may also indicate why the triplet repeats are more 
prone to delete in subsequent rounds of replication (91,128,134,213) as opposed to the 
CCTG•CAGG repeats that are stably maintained (unpublished data).  Furthermore, the 
MMR pathway has been shown in previous work (213,215,216,219,221,223) to be 
involved in generating the instabilities of the CTG•CAG sequence; however, the MMR 
proteins do not influence the instabilities of the CCTG•CAGG repeats (unpublished 
data).  This could again be suggestive of a repair-escape mechanism by the relatively 
transient and unstable structure formed at the tetranucleotide repeats. 
Studies using intramolecular assays for measuring recombination events have 
shown this process to be independent of RecA, although recombination was stimulated 
to give high frequencies in its presence (201,347-351).  Previous studies on double-
strand breaks (DSBs) have shown that breaks within the repeat tracts can lead to 
instability [reviewed in (4,6,7)].  If multiple breaks occur during the cell cycle, various 
checkpoint pathways may be activated to repair the damage before the cell can divide.  
The SOS response in bacteria is one such mechanism that controls the expression of 
almost 40 genes, most of which are involved in the repair of damage (344).  To evaluate 
the involvement of the SOS-repair pathway, we determined recombination frequencies 
in three SOS mutant strains.  The SOS parental strain was E. coli JJC510.  The JJC523 
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and JJC123 strains contain LexA variants that enable constitutive induction of the SOS 
pathway or prevent RecA-dependent cleavage thus inactivating the SOS response, 
respectively.  Our results showed that high recombination frequencies were obtained for 
pRW5231 [(CCTG•CAGG)160, orientation II] in JJC510 and JJC523 (15 and 9 %, 
respectively).  On the contrary, the recombination frequency dropped significantly (to 4 
%) in the SOS¯ E. coli JJC123.  Thus, a dramatic and significant reduction in 
recombination frequency was obtained for the different lengths of the CCTG•CAGG 
repeats in the SOS-deficient strain.   
In order to evaluate the levels of induction of the SOS response, we assayed for 
β-galactosidase activity.  These data showed that the SOS response was not induced.  
This led to the question of why the recombination frequencies were so dramatically 
different in the isogenic strains used in our assay.  The differences between the SOS+ 
strains and the SOS¯ strain may potentially be due to different basal levels of some gene 
products under SOS regulation.  The lack of these basal levels in the SOS deficient strain 
may be responsible for the lower levels of recombination observed in this strain.  The 
frequencies of recombination obtained in JJC523 (constitutively expressed SOS strain) 
were lower than those observed in the parental strain which may suggest a suppressive 
effect on the recombination pathway, being exerted by one of the many proteins 
expressed constitutively in this strain.  Thus, the complexity of the SOS response and the 
multiple pathways that it could influence makes it difficult to pinpoint any single gene 
product or pathway responsible for the observed differences in recombination 
frequencies between the three SOS mutant strains. 
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The model proposed in Fig. 16A hypothesis the formation of a break in a single 
tract (Y tract) and its subsequent repair by a homologous recombination mediated 
mechanism.  Another possible model (Fig. 16B) proposes the formation of DSBs in both 
the repeat tracts (step G).  The plasmids used in our studies are transcribed and contain 
one repeat tract downstream of the transcribed GFP gene and the other upstream of the 
same gene.  The waves of negative supercoiling behind (upstream of) the RNA 
polymerase may influence the formation of the non-B DNA structures in vivo (153,356).  
The formation of these structures upstream of the progressing transcription apparatus 
could lead to formation of breaks in the X-tract.  Thus two DSBs could form 
simultaneously in both the X and Y tracts (Fig. 16B).  A mechanism that is known to act 
on DSBs in plasmids is single strand annealing (SSA) (321,326,332,333,336-339) (steps 
H and I).  This is a non-conservative repair mechanism where the DSB is processed 
leading to the annealing of the complementary strands.  This is another possible 
mechanism as shown in Fig. 16B that could lead to the products observed in our studies. 
Thus, the CCTG•CAGG repeats are recombination hotspots prone to expand.  
The large expansions associated with DM2 could occur as a result of the DNA 
conformational properties of these repeats.  Studies aimed at inhibiting the formation of 
secondary structures by manipulating the conditions favoring their formation may 
provide an encouraging therapeutic strategy in the future.   
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
 The triplet repeat sequences and the mechanisms of expansions associated with 
these diseases have been studied extensively for the past decade and a half (4-7).  The 
experiments designed herein, were aimed at understanding the molecular mechanisms of 
DM2, which is the first tetranucleotide to cause a hereditary neurological disorder.  DM2 
is characterized by the massive expansion of the CCTG•CAGG repeats from < 30 
repeats to almost 11,000 repeats (236).  This is the largest expansion observed in the 
category of repeating neurological disorders.  By using both the simple and well defined 
E. coli model, as well as a more complex African green monkey kidney cell culture 
(COS-7) system we have proposed a number of mechanisms including non-B DNA 
structures, replication-slippage, and recombination-repair to influence the genetic 
instabilities of DM2. 
 Replication-slippage in previous studies with the TRS has been proposed as a 
potential mechanism of genetic instability [reviewed in (6,7,38)].  Our experiments in 
COS-7 cells showed that replication-based slippage of the CCTG•CAGG repeats could 
occur in this system, to yield both expansions and deletions (Chapter II).  This instability 
was found to be dependent on the length of the repeats, orientation and proximity of the 
repeat tracts to the SV40 origin of replication.  Additionally, biochemical studies on 
synthetic oligonucleotides revealed the structure-forming propensity of the d(CAGG)26 
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oligomer as compared to its complementary d(CCTG)26 oligonucleotide that did not 
form any preferential structure in our studies.   
 Although replication-slippage yielded both expansions and deletions, it would be 
rather difficult to explain the massive expansions associated with DM2, solely by this 
mechanism.  Using an intramolecular genetic assay in E. coli we showed the 
CCTG•CAGG repeats to be recombination hotspots (Chapter III).  The recombination 
frequencies obtained with the tetranucleotide repeats were up to 27-fold higher than the 
non-repeating control.  Additionally, on analyzing the products of recombination a large 
percentage of expanded clones were obtained contrary to the large number of deleted 
clones obtained in similar work with the TRS (CTG•CAG and GAA•TTC).  Moreover, 
we determined that although high recombination frequencies were obtained in SOS+ 
strains as opposed to the SOS¯ strain, the SOS response itself was not being induced in 
our studies.   
 The molecular mechanisms investigated herein, will be important to develop 
future therapeutic strategies aimed at this disease.  The ability of the CCTG•CAGG 
repeats to adopt non-B DNA conformations seems to play an important role in 
generating the instabilities associated with DM2 in our model systems.  A better 
understanding of the molecular mechanisms causing such expansions, including the 
conditions favoring the formation of non-B DNA structures, could lead to the 
development of various strategies for therapeutic intervention.   
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